AST SpaceMobile (ASTS) S-1 25 Jun 21 IPO registration Financial data

Document and Entity Information

Document and Entity Information	3 Months Ended
	Mar. 31, 2021
Cover [Abstract]
Entity Registrant Name	AST SPACEMOBILE, INC.
Entity Central Index Key	0001780312
Document Type	S-1
Amendment Flag	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 50,052,736	$ 131,151	$ 493,128
Prepaid expenses	47,667	23,278	131,226
Prepaid income tax	54,439	54,439
Total Current Assets	50,154,842	208,868	624,354
Marketable securities held in Trust Account	231,913,996	232,196,027	231,214,831
TOTAL ASSETS	282,068,838	232,404,895	231,839,185
Current Liabilities
Accounts payable and accrued expenses	1,258,263	634,286	240,138
Promissory note - related party	600,000
Income taxes payable			25,684
Total Current Liabilities	1,858,263	634,286	265,822
Deferred tax liability		9,680	3,611
Deposit from investors	50,000,000
Deferred underwriting fee payable	8,050,000	8,050,000	8,050,000
Warrant liabilities	66,086,000	68,114,000	15,962,000
Total Liabilities	125,994,263	76,807,966	24,281,433
Commitments and Contingencies (Note 7)
Class A common stock subject to possible redemption, 14,982,488 , 14,922,915 and 20,157,878 shares at redemption value as of March 31, 2021, December 31, 2020 and December 31, 2019, respectively	151,074,574	150,596,928	202,557,751
Stockholders' Equity
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	59,243,594	59,840,653	7,880,362
Accumulated Deficit	(54,245,116)	(54,842,168)	(2,881,345)
Total Stockholders' Equity	5,000,001	5,000,001	5,000,001
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	282,068,838	232,404,895	231,839,185
Class A Common Stock [Member]
Stockholders' Equity
Common stock value	948	941	409
Class B Common Stock [Member]
Stockholders' Equity
Common stock value	$ 575	$ 575	$ 575

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Common stock, shares subject to possible redemption	$ 14,982,488	$ 14,922,915	$ 20,157,878
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Class A Common Stock [Member]
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, shares issued	8,017,512	8,077,085	2,842,122
Common stock, shares outstanding	8,017,512	8,077,085	2,842,122
Class B Common Stock [Member]
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares authorized	10,000,000	10,000,000	10,000,000
Common stock, shares issued	5,750,000	5,750,000	5,750,000
Common stock, shares outstanding	5,750,000	5,750,000	5,750,000

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		7 Months Ended	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Income Statement [Abstract]
Operating costs	$ 1,434,836	$ 185,257	$ 384,857	$ 1,124,693
Loss from operations	(1,434,836)	(185,257)	(384,857)	(1,124,693)
Other income:
Changes in fair value of warrant liabilities	2,028,000	6,925,000	(3,053,000)	(52,152,000)
Interest income on marketable securities held in Trust Account	21,197	886,099	1,197,637	1,479,986
Issuance costs allocated to warrant liabilities			(484,024)
Unrealized gain on marketable securities held in Trust Account		371,628	17,194	1,830
Other income	2,049,197	8,182,727	(2,322,193)	(50,670,184)
Profit before income taxes	614,361	7,997,470	(2,707,050)	(51,794,877)
Provision for income taxes	(17,309)	(225,218)	(174,295)	(165,946)
Net Income	$ 597,052	$ 7,772,252	$ (2,881,345)	$ (51,960,823)
Weighted average common shares subject to possible redemption outstanding, basic and diluted	14,922,915	20,157,878	10,207,641	20,151,440
Basic and diluted income per common share subject to possible redemption	$ 0	$ 0.04	$ 0.08	$ 0.04
Weighted average shares outstanding, basic and diluted	13,827,085	8,592,122	6,111,484	8,598,542
Basic and diluted net income per non-redeemable common share	$ 0.04	$ 0.8	$ (0.61)	$ (6.13)

Condensed Statements of Changes

Condensed Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)	Class A Common Stock [Member]	Class B Common Stock [Member]	Additional Paid-In Capital [Member]	(Accumulated Deficit) Retained Earnings [Member]	Total
Balance at May. 27, 2019
Balance, shares at May. 27, 2019
Class B common stock issued to the Sponsor		$ 575	24,425		25,000
Class B common stock issued to the Sponsor, shares		5,750,000
Sale of 23,000,000 Units, net of warranty liability, underwriting discounts, and offering expenses	$ 2,300		208,825,797		$ 208,828,097
Sale of 23,000,000 Units, net of warranty liability, underwriting discounts, and offering expenses, shares	23,000,000				23,000,000
Payment above fair value upon sale of 6,100,000 Private Placement Warrants			1,586,000		$ 1,586,000
Change in value of Class A common stock subject to possible redemption	$ (1,891)		(202,555,860)		(202,557,751)
Change in value of Class A common stock subject to possible redemption, shares	(20,157,878)
Net income				(2,881,345)	(2,881,345)
Balance at Dec. 31, 2019	$ 409	$ 575	7,880,362	(2,881,345)	5,000,001
Balance, shares at Dec. 31, 2019	2,842,122	5,750,000
Change in value of Class A common stock subject to possible redemption	$ (68)		(7,772,184)		(7,772,252)
Change in value of Class A common stock subject to possible redemption, shares	(691,202)
Net income				7,772,252	7,772,252
Balance at Mar. 31, 2020	$ 341	$ 575	108,178	4,890,907	5,000,001
Balance, shares at Mar. 31, 2020	2,150,920	5,750,000
Balance at Dec. 31, 2019	$ 409	$ 575	7,880,362	(2,881,345)	5,000,001
Balance, shares at Dec. 31, 2019	2,842,122	5,750,000
Net income					(903,725)
Balance at Jun. 30, 2020					5,000,001
Balance at Dec. 31, 2019	$ 409	$ 575	7,880,362	(2,881,345)	5,000,001
Balance, shares at Dec. 31, 2019	2,842,122	5,750,000
Net income					(4,654,774)
Balance at Sep. 30, 2020					5,000,001
Balance at Dec. 31, 2019	$ 409	$ 575	7,880,362	(2,881,345)	$ 5,000,001
Balance, shares at Dec. 31, 2019	2,842,122	5,750,000
Sale of 23,000,000 Units, net of warranty liability, underwriting discounts, and offering expenses, shares					23,000,000
Change in value of Class A common stock subject to possible redemption	$ 532		51,960,291		$ 51,960,823
Change in value of Class A common stock subject to possible redemption, shares	5,234,963
Net income				(51,960,823)	(51,960,823)
Balance at Dec. 31, 2020	$ 941	$ 575	59,840,653	(54,842,168)	5,000,001
Balance, shares at Dec. 31, 2020	8,077,085	5,750,000
Balance at Mar. 31, 2020	$ 341	$ 575	108,178	4,890,907	5,000,001
Balance, shares at Mar. 31, 2020	2,150,920	5,750,000
Net income					(8,675,977)
Balance at Jun. 30, 2020					5,000,001
Net income					(3,751,049)
Balance at Sep. 30, 2020					5,000,001
Balance at Dec. 31, 2020	$ 941	$ 575	59,840,653	(54,842,168)	5,000,001
Balance, shares at Dec. 31, 2020	8,077,085	5,750,000
Change in value of Class A common stock subject to possible redemption	$ 7		(597,059)		(597,052)
Change in value of Class A common stock subject to possible redemption, shares	(59,573)
Net income				597,052	597,052
Balance at Mar. 31, 2021	$ 948	$ 575	$ 59,243,594	$ (54,245,116)	$ 5,000,001
Balance, shares at Mar. 31, 2021	8,017,512	5,750,000

Condensed Statements of Chang_2

Condensed Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical)	7 Months Ended
	Dec. 31, 2019shares
Sale of units, net of warranty liability, underwriting discounts, and offering expenses, shares	23,000,000
Private Placement [Member]
Warrant outstanding	6,100,000

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		4 Months Ended	7 Months Ended	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Sep. 30, 2019	Dec. 31, 2019	Dec. 31, 2020
Cash Flows from Operating Activities:
Net income	$ 597,052	$ 7,772,252	$ (573,356)	$ (2,881,345)	$ (51,960,823)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on securities held in Trust Account	(21,197)	(886,099)		(1,197,637)	(1,479,986)
Unrealized loss on securities held in Trust Account		(371,628)		(17,194)	(1,830)
Deferred income provision (benefit)	(9,680)	74,431		3,611	6,069
Change in fair value of warrant liabilities	(2,028,000)	(6,925,000)	176,000	3,053,000	52,152,000
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(24,389)	(9,016)		(131,226)	107,948
Prepaid income taxes					(54,439)
Accounts payable and accrued expenses	623,977	3,626		240,138	394,148
Income tax payable		150,787		25,684	(25,684)
Net cash used in operating activities	(862,237)	(190,647)	(692,713)	(904,969)	(862,597)
Cash Flows from Investing Activities:
Investment of cash in trust				(230,000,000)
Interest withdrawn for tax payments	303,228	217,146			500,620
Net cash used in investing activities	303,228	217,146		(230,000,000)	500,620
Cash Flows from Financing Activities:
Proceeds from Investors due to PIPE Financing	50,000,000
Proceeds from sale of Units, net of underwriting discounts paid			225,884,024	225,884,024
Proceeds from sale of Private Placement Warrants				6,100,000
Proceeds from promissory note - related party	600,000			155,093
Repayment of promissory note - related party				(155,093)
Payments of offering costs				(585,927)
Redemption of Common Shares	(119,406)
Net cash provided by financing activities	50,480,594		231,398,097	231,398,097
Net Change in Cash	49,921,585	26,499		493,128	(361,977)
Cash - Beginning	131,151	493,128			493,128
Cash - Ending	50,052,736	519,627		493,128	131,151
Supplemental cash flow information:
Cash paid for income taxes	26,989				240,000
Non-cash investing and financing activities:
Initial classification of ordinary shares subject to redemption			204,953,919	204,953,910
Change in value of shares subject to redemption	$ 477,646	$ 7,772,252	$ (88,179)	(2,396,159)	(51,960,823)
Deferred offering costs paid directly by Sponsor from proceeds from issuance of ordinary shares				25,000
Deferred underwriting fee				$ 8,050,000

Description of Organization and

Description of Organization and Business Operations	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Organization and Business Operations	Note 1 — Description of Organization and Business Operations As of March 31, 2021, New Providence Acquisition Corp., a Delaware corporation (“NPA”, or the “the Company”), our predecessor, was a blank check company incorporated in Delaware on May 28, 2019. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. On April 6, 2021 (the “Closing Date”), NPA completed the previously announced business combination (the “Business Combination”) pursuant to that certain Equity Purchase Agreement, dated as of December 15, 2020 (the “Equity Purchase Agreement”), by and among NPA, AST & Science LLC, a Delaware limited liability company (“AST”), the existing equityholders of AST, New Providence Acquisition Management LLC, a Delaware limited liability company (“Sponsor”), and Abel Avellan. Immediately, upon the completion of the Business Combination, NPA was renamed AST SpaceMobile, Inc. and AST became a subsidiary of the AST SpaceMobile, Inc.. The Business Combination is documented in greater detail at Note 10. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of March 31, 2021, the Company had not commenced any operations. All activity through March 31, 2021 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, after the Initial Public Offering, the Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on September 10, 2019. On September 13, 2019, the Company completed the Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), generating gross proceeds of $200,000,000, which is described in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company completed the sale of 5,500,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to New Providence Management LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $5,500,000, which is described in Note 4. Following the closing of the Initial Public Offering on September 13, 2019, an amount of $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below. On September 19, 2019, in connection with the underwriters’ election to fully exercise their over-allotment option, the Company completed the sale of an additional 3,000,000 Units at $10.00 per Unit and the sale of an additional 600,000 Private Placement Warrants at $1.00 per Private Placement Warrant, generating total gross proceeds of $30,600,000. Following the closing, an additional $30,000,000 of net proceeds was deposited into the Trust Account, resulting in $230,000,000 held in the Trust Account. Transaction costs incurred in connection with the Initial Public Offering amounted to $13,260,927, consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees and $610,927 of other offering costs. The Company’s Certificate of Incorporation provides for the Company to have until March 15, 2021 (the “Combination Period”) to complete a Business Combination or obtain a Charter Extension from Shareholders. A Charter Extension was proposed and adopted at the Annual Meeting on March 12, 2021, amending the Existing Certificate of Incorporation to extend the March 15, 2021 deadline for completing a business combination to June 15, 2021. On April 6, 2021, the Company completed the previously announced Business Combination, which is discussed in greater detail at Note 10. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of trust assets, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.	NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS New Providence Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on May 28, 2019. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity through December 31, 2020 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on September 10, 2019. On September 13, 2019, the Company consummated the Initial Public Offering of 20,000,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), generating gross proceeds of $200,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 5,500,000 warrants (the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to New Providence Management LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $5,500,000, which is described in Note 5. Following the closing of the Initial Public Offering on September 13, 2019, an amount of $200,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act of 1940, as amended (the “Investment Company Act”), as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account to the Company’s stockholders, as described below. On September 19, 2019, in connection with the underwriters’ election to fully exercise their over-allotment option, the Company consummated the sale of an additional 3,000,000 Units at $10.00 per Unit and the sale of an additional 600,000 Private Placement Warrants at $1.00 per Private Placement Warrant, generating total gross proceeds of $30,600,000. Following the closing, an additional $30,000,000 of net proceeds was deposited into the Trust Account, resulting in $230,000,000 held in the Trust Account. Transaction costs incurred in connection with the Initial Public Offering amounted to $13,260,927, consisting of $4,600,000 of underwriting fees, $8,050,000 of deferred underwriting fees and $610,927 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its stockholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then in the Trust Account ($10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to stockholders who redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 8). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. If a stockholder vote is not required and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”) and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased by it during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, regardless of whether they vote for or against a Business Combination. If the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking redemption rights with respect to 15% or more of the Public Shares, without the Company’s prior written consent. The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment. The Company will have until March 15, 2021 (the “Combination Period”) to consummate a Business Combination or obtain a Charter Extension from Shareholders. If the Company is unable to complete a Business Combination in the Combination Period or obtain a Charter Extension from Shareholders, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period. The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, the Sponsor will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares purchased by it during or after the Initial Public Offering if the Company fails to complete its Business Combination. The underwriters have agreed to waive their rights to their deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of trust assets, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavouring to have all vendors, service providers (except the Company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Liquidity and Going Concern As of December 31, 2020, the Company had $131,151 in its operating bank accounts, $232,196,027 in marketable securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its Public Shares in connection therewith and an adjusted working capital deficit of $337,484 (excluding franchise taxes payable and prepaid income tax). As of December 31, 2020, $2,196,027 of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company’s tax obligations, if any. On January 28, 2021 and on February 18, 2021, the Sponsor agreed to loan the Company $200,000 and $500,000 for an aggregate up to $700,000, respectively. The promissory notes (“Notes”) are provided to cover certain expenses related to the business combination, of which $300,000 was drawn down as of February 26, 2021 (see Note 12). Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating target businesses, performing due diligence on prospective target businesses, traveling to and from the offices, plants or similar location of prospective target businesses or their representatives or owners, reviewing corporate documents and material agreements of prospective target businesses and structuring, negotiating and completing a Business Combination. The Company will need to raise additional capital through loans or additional investments from its Sponsor, an affiliate of the Sponsor, or its officers or directors. The Company’s officers, directors and Sponsor, or their affiliates, may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern through March 31, 2021, which is the date the Company is required cease all operations except for the purpose of winding up if it has not completed a Business Combination. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Restatement of Financial Statem

Restatement of Financial Statements	12 Months Ended
	Dec. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Restatement of Financial Statements	NOTE 2 — RESTATEMENT OF FINANCIAL STATEMENTS Restatement Background and Explanation The Company has restated its financial statements as of December 31, 2020 and 2019 and for the year ended December 31, 2020 and for the period from May 28, 2019 (inception) through December 31, 2019, and the interim periods ended September 30, 2020 and 2019, March 31, 2020, and June 30, 2020, as well as the financial statements as of September 13, 2019 (collectively “Affected Periods”), to correct misstatements in those prior periods related to misstatements identified in improperly applying accounting guidance on certain warrants, recognizing them as equity instead of warrant liabilities, under the guidance of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 815-40, Contracts in Entity’s Own Equity. The Company issued Public and Private Warrants in September 2019, collectively, aggregating to 11,500,000 and 6,100,000 warrants, respectively, issued between two closings. Each whole Public and Private Warrant is exercisable to purchase one share of Class A Common Stock at a price of $11.50 per share. Upon issuance of the warrants, the Company conducted an evaluation pursuant to ASC 815 to determine the appropriate classification within the financial statements. The Company concluded that the warrants should be recorded at their issuance price within stockholders’ equity in the balance sheet. The determination to classify the warrants within stockholders’ equity was primarily based on the understanding that the settlement provisions of the warrants did not allow for net cash settlement in an event that was outside of the Company’s control in which all holders of the underlying shares, into which the warrants are exercisable, also would receive cash. Upon the release of the SEC Statement on April 12, 2021, the Company re-assessed its classification of its warrants under ASC 815 pursuant to the accounting policy described in Note 3. Pursuant to the terms of the warrants, upon a cash tender offer in which 50% or more of the outstanding shares of common stock participate, the holders of the warrants shall be entitled to redeem the warrants and receive the highest amount of cash, securities, or other property to which such holder would have been entitled as a stockholder if the holder of the warrants had exercised the warrants prior to the expiration of such tender offer and accepted such tender offer. Upon the occurrence of such event, which is outside of the control of the Company, the warrants would be net cash settled and not all holders of the common stock may receive cash (assuming not all outstanding shares accepted the tender offer). The Company recognized that ASC 815 precludes the classification of a freestanding financial instrument within stockholder’s equity when an event that is outside the entity’s control could require net cash settlement in which not all of the holders of the underlying shares also receive cash. Therefore, based on the results of the Company’s assessment, the Company has concluded that the warrants issued in September 2019 are freestanding instruments which should be accounted for as warrant liabilities rather than as a component of additional paid-in capital on the balance sheet, with any subsequent changes in the estimated fair value of the warrants reported in the statement of operations. Impact of the Restatement The impact of the restatement on the balance sheets, statements of operations, and statements of cash flows for the Affected Periods is presented below. Impact of the Restatement – 2020 Balance Sheets December 31, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 68,114,000 $ 68,114,000 Total liabilities 8,693,966 68,114,000 76,807,966 Class A common stock subject to possible redemption 218,710,925 (68,113,997 ) 150,596,928 Class A common stock 133 808 941 Addition paid-in capital 4,152,440 55,688,213 59,840,653 Retained earnings (accumulated deficit) 846,856 (55,689,024 ) (54,842,168 ) Total stockholders’ equity (deficit) 5,000,004 (3 ) 5,000,001 Statements of Operations For the Year Ended December 31, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (52,152,000 ) $ (52,152,000 ) Other income (expense), net 1,481,816 (52,152,000 ) (50,670,184 ) Net income (loss) 191,177 (52,152,000 ) (51,960,823 ) Weighted average shares outstanding, basic and diluted 7,008,667 1,589,875 8,598,542 Basic and diluted net loss per common share $ (0.12 ) $ (6.01 ) $ (6.13 ) Statements of Cash Flows For the Year Ended December 31, 2020 As Reported Adjustments As Revised Net income (loss) $ 191,177 $ (52,152,000 ) $ (51,960,823 ) Change in fair value of warrant liabilities - 52,152,000 52,152,000 Non-cash investing and financing activities: Change in value of shares subject to redemption 191,177 (52,152,000 ) (51,960,823 ) Balance Sheets September 30, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 21,357,000 $ 21,357,000 Total liabilities 8,310,507 21,357,000 29,667,507 Class A common stock subject to possible redemption 219,259,970 (21,356,993 ) 197,902,977 Class A common stock 127 338 465 Additional paid-in capital 3,603,401 8,931,679 12,535,080 Retained earnings (accumulated deficit) 1,395,905 (8,932,024 ) (7,536,119 ) Total stockholders’ equity (deficit) 5,000,008 (7 ) 5,000,001 Statements of Operations Three Months Ended September 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (3,696,000 ) $ (3,696,000 ) Other income (expense), net 83,140 (3,696,000 ) (3,612,860 ) Net income (loss) (55,049 ) (3,696,000 ) (3,751,049 ) Weighted average shares outstanding, basic and diluted 7,007,989 1,750,840 8,758,829 Basic and diluted net loss per common share $ (0.01 ) $ (0.42 ) $ (0.43 ) Statements of Operations Nine Months Ended September 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (5,395,000 ) $ (5,395,000 ) Other income (expense), net 1,429,005 (5,395,000 ) (3,965,995 ) Net income (loss) 740,226 (5,395,000 ) (4,654,774 ) Weighted average shares outstanding, basic and diluted 5,307,098 3,111,439 8,418,537 Basic and diluted net loss per common share $ (0.02 ) $ (0.64 ) $ (0.66 ) Statements of Cash Flows Nine Months Ended September 30, 2020 As Reported Adjustments As Revised Net income (loss) $ 740,226 $ (5,395,000 ) $ (4,654,774 ) Change in fair value of warrant liabilities - 5,395,000 5,395,000 Non-cash investing and financing activities: Change in value of shares subject to redemption 740,222 (4,491,271 ) (3,751,049 ) Balance Sheets June 30, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 17,661,000 $ 17,661,000 Total liabilities 8,256,307 17,661,000 25,917,307 Class A common stock subject to possible redemption 219,315,022 (17,660,996 ) 201,654,026 Class A common stock 126 301 427 Additional paid-in capital 3,548,350 5,235,719 8,784,069 Retained earnings (accumulated deficit) 1,450,954 (5,236,024 ) (3,785,070 ) Total stockholders’ equity (deficit) 5,000,005 (4 ) 5,000,001 Statements of Operations Three Months Ended June 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (8,624,000 ) $ (8,624,000 ) Other income (expense), net 88,138 (8,624,000 ) (8,535,862 ) Net income (loss) (51,977 ) (8,624,000 ) (8,675,977 ) Weighted average shares outstanding, basic and diluted 7,005,122 895,798 7,900,920 Basic and diluted net loss per common share $ (0.01 ) $ (1.09 ) $ (1.10 ) Statements of Operations Six Months Ended June 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (1,699,000 ) $ (1,699,000 ) Other income (expense), net 1,345,865 (1,699,000 ) (353,135 ) Net income (loss) 795,275 (1,699,000 ) (903,725 ) Weighted average shares outstanding, basic and diluted 7,004,380 1,242,141 8,246,521 Basic and diluted net loss per common share $ (0.03 ) $ (0.19 ) $ (0.22 ) Statements of Cash Flows Six Months Ended June 30, 2020 As Reported Adjustments As Revised Net income (loss) $ 795,275 $ (1,699,000 ) $ (903,725 ) Change in fair value of warrant liabilities - 1,699,000 1,699,000 Non-cash investing and financing activities: Change in value of shares subject to redemption 795,274 (9,471,251 ) (8,675,977 ) Balance Sheets March 31, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 9,037,000 $ 9,037,000 Total liabilities 8,548,277 9,037,000 17,585,277 Class A common stock subject to possible redemption 219,367,001 (9,036,998 ) 210,330,003 Class A common stock 126 215 341 Additional paid-in capital 3,496,371 (3,388,193 ) 108,178 Retained earnings 1,502,931 3,387,976 4,890,907 Total stockholders’ equity (deficit) 5,000,003 (2 ) 5,000,001 Statements of Operations Three Months Ended March 31, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ 6,925,000 $ 6,925,000 Other income, net 1,257,727 6,925,000 8,182,727 Net income 847,252 6,925,000 7,772,252 Weighted average shares outstanding, basic and diluted 7,003,637 1,588,485 8,592,122 Basic and diluted net income (loss) per common share $ (0.01 ) $ 0.81 $ 0.80 Statements of Cash Flows Three Months Ended March 31, 2020 As Reported Adjustments As Revised Net income $ 847,252 $ 6,925,000 $ 7,772,252 Change in fair value of warrant liabilities - (6,925,000 ) (6,925,000 ) Non-cash investing and financing activities: Change in value of shares subject to redemption 847,253 6,924,999 7,772,252 Impact of the Restatement – 2019 Balance Sheets December 31, 2019 As Reported Adjustments As Revised Warrant liabilities $ - $ 15,962,000 $ 15,962,000 Total liabilities 8,319,433 15,962,000 24,281,433 Class A common stock subject to possible redemption 218,519,748 (15,961,997 ) 202,557,751 Class A common stock 125 284 409 Addition paid-in capital 4,343,625 3,536,737 7,880,362 Retained earnings (accumulated deficit) 655,679 (3,537,024 ) (2,881,345 ) Total stockholders’ equity (deficit) 5,000,004 (3 ) 5,000,001 Statements of Operations For the Period From May 28, 2019 (inception) through December 31, 2019 As Reported Adjustments As Revised Changes in fair value of warrant liabilities - (3,053,000 ) (3,053,000 ) Issuance costs allocated to warrant liabilities - (484,024 ) (484,024 ) Other income (expense), net 1,214,831 (3,537,024 ) (2,322,193 ) Net income (loss) 655,679 (3,537,024 ) (2,881,345 ) Weighted average shares outstanding, basic and diluted 6,075,732 35,752 6,111,484 Basic and diluted net loss per common share $ (0.04 ) $ (0.57 ) $ (0.61 ) Statements of Cash Flows For the Period From May 28, 2019 (inception) through December 31, 2019 As Reported Adjustments As Revised Operating Activities: Net income (loss) $ 655,679 $ (3,537,024 ) $ (2,881,345 ) Change in fair value of warrant liabilities - 3,053,000 3,053,000 Net cash used in operating activities (420,945 ) (484,024 ) (904,969 ) Financing Activities: Proceeds from sale of Units, net of underwriting discounts paid 225,400,000 484,024 225,884,024 Net cash provided by financing activities 230,914,073 484,024 231,398,097 Non-cash investing and financing activities: Initial classification of ordinary shares subject to redemption 217,862,910 (12,909,000 ) 204,953,910 Change in value of shares subject to redemption 656,838 (3,052,997 ) (2,396,159 ) Balance Sheets September 30, 2019 As Reported Adjustments As Revised Warrant liabilities $ - $ 13,085,000 $ 13,085,000 Total liabilities 8,125,774 13,085,000 21,210,774 Class A common stock subject to possible redemption 217,950,740 (13,085,000 ) 204,865,740 Class A common stock 122 253 375 Additional paid-in capital 4,912,636 659,771 5,572,407 Retained earnings (accumulated deficit) 86,668 (660,024 ) (573,356 ) Statements of Operations Three Months Ended September 30, 2019 As Reported Adjustments As Revised Changes in fair value of warrant liabilities - (176,000 ) (176,000 ) Issuance costs allocated to warrant liabilities - (484,024 ) (484,024 ) Other income (expense), net 205,420 (660,024 ) (454,604 ) Net income (loss) 87,761 (660,024 ) (572,263 ) Weighted average shares outstanding, basic and diluted 5,307,098 228,499 5,535,597 Basic and diluted net income (loss) per common share $ (0.02 ) $ (0.11 ) $ (0.13 ) Statements of Operations For the Period From May 28, 2019 (inception) through September 30, 2019 As Reported Adjustments As Revised Changes in fair value of warrant liabilities - (176,000 ) (176,000 ) Issuance costs allocated to warrant liabilities - (484,024 ) (484,024 ) Other income (expense), net 205,420 (660,024 ) (454,604 ) Net income (loss) 86,668 (660,024 ) (573,356 ) Weighted average shares outstanding, basic and diluted 5,274,301 (760,101 ) 4,514,200 Basic and diluted net income (loss) per common share $ (0.02 ) $ (0.14 ) $ (0.16 ) Statements of Cash Flows For the Period From May 28, 2019 (inception) through September 30, 2019 As Reported Adjustments As Revised Operating Activities: Net income (loss) $ 86,668 $ (660,024 ) $ (573,356 ) Change in fair value of warrant liabilities - 176,000 176,000 Net cash used in operating activities (208,689 ) (484,024 ) (692,713 ) Financing Activities: Proceeds from sale of Units, net of underwriting discounts paid 225,400,000 484,024 225,884,024 Net cash provided by financing activities 230,914,073 484,024 231,398,097 Non-cash investing and financing activities: Initial classification of ordinary shares subject to redemption 217,862,910 (12,908,991 ) 204,953,919 Change in value of shares subject to redemption 87,830 (176,009 ) (88,179 ) Balance Sheets September 13, 2019 As Reported Adjustments As Revised Warrant liabilities $ - $ 11,370,000 $ 11,370,000 Total liabilities 8,084,093 11,370,000 19,454,093 Class A common stock subject to possible redemption 188,912,910 (11,369,991 ) 177,542,919 Class A common stock 111 114 225 Additional paid-in capital 5,000,477 423,676 5,424,153 Retained earnings (accumulated deficit) (1,153 ) (423,799 ) (424,952 ) Total stockholders’ equity (deficit) 5,000,010 (9 ) 5,000,001

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2020 as filed with the SEC on May 6, 2021, which contains the audited financial statements and notes thereto. The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020. Cash and Marketable Securities Held in Trust Account At March 31, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. During the three months ended March 31, 2021, the Company withdrew $303,228 of interest earned on the Trust Account to pay its franchise and income taxes. Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in the ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). Management’s assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period-end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, they are recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, they are recorded at their initial fair value on the date of issuance and subject to remeasurement each balance sheet date with changes in the estimated fair value of the warrants to be recognized as a non-cash gain or loss in the statement of operations. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net Income Per Common Share Net income per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at March 31, 2021 and 2020, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic income per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 17,600,000 shares of common stock. As a result, diluted income per common share is the same as basic income per common share for the periods presented. Reconciliation of Net Income Per Common Share The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted income per common share is calculated as follows: For the Three Months Ended March 31 2021 March 31 2020 Net income 597,052 7,772,252 Less: Income attributable to common stock subject to possible redemption 27,616 890,626 Adjusted net income 569,436 6,881,626 Weighted average common shares subject to possible redemption outstanding, basic and diluted 14,922,915 20,157,878 Basic and diluted income per common share subject to possible redemption 0.00 0.04 Weighted average non-redeemable common shares outstanding, basic and diluted 13,827,085 8,592,122 Basic and diluted net loss per non-redeemable common share 0.04 0.80 Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments U.S. GAAP requires disclosing the fair value of financial instruments to the extent practicable for financial instruments which are recognized or unrecognized in the balance sheet. The fair value of the financial instruments disclosed herein is not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. In assessing the fair value of financial instruments, the Company uses a variety of methods and assumptions, which are based on estimates of market conditions and risks existing at the time. For certain instruments, including cash, accounts receivable, accounts payable, and accrued expenses, it was estimated that the carrying amount approximated fair value because of the short maturities of these instruments. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.	NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020 and, 2019. Cash and Marketable Securities Held in Trust Account At December 31, 2020 and, 2019, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. During the year ended December 31, 2020, the Company withdrew $500,620 of interest earned on the Trust Account to pay its franchise and income taxes. Class A common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”). Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets. Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in the ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). Management’s assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period-end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, they are recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, they are recorded at their initial fair value on the date of issuance and subject to remeasurement each balance sheet date with changes in the estimated fair value of the warrants to be recognized as a non-cash gain or loss in the statement of operations. Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOL) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company’s financial position or statement of operations. Net Loss Per Common Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at December 31, 2020 and 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 17,600,000 shares of common stock. As a result, diluted loss per common share is the same as basic loss per common share for the periods presented. Reconciliation of Net Loss Per Common Share The Company’s net income (loss) is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted net loss per common share is calculated as follows: For the year Ended December 31, 2020 For the Period from May 28, 2019 (inception) through December 31, 2019 Net loss $ (51,960,823 ) $ (2,881,345 ) Less: Income attributable to common stock subject to possible redemption (723,829 ) (848,726 ) Adjusted net loss (52,684,652 ) (3,730,070 ) Weighted average common shares subject to possible redemption outstanding, basic and diluted 20,151,440 10,207,641 Basic and diluted income per common share subject to possible redemption 0.04 0.08 Weighted average shares outstanding, basic and diluted 8,598,542 6,111,484 Basic and diluted net loss per non-redeemable common share $ (6.13 ) $ (0.61 ) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments U.S. GAAP requires disclosing the fair value of financial instruments to the extent practicable for financial instruments which are recognized or unrecognized in the balance sheet. The fair value of the financial instruments disclosed herein is not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. In assessing the fair value of financial instruments, the Company uses a variety of methods and assumptions, which are based on estimates of market conditions and risks existing at the time. For certain instruments, including cash, accounts receivable, accounts payable, and accrued expenses, it was estimated that the carrying amount approximated fair value because of the short maturities of these instruments. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Initial Public Offering	Note 3 — Initial Public Offering Pursuant to the Initial Public Offering, the Company sold 20,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one warrant (“Public Warrant”). On September 19, 2019, in connection with the underwriters’ exercise of the over-allotment option in full, the Company sold an additional 3,000,000 Units at a price of $10.00 per Unit. Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 8).	NOTE 4 — INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 20,000,000 Units at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one-half of one warrant (“Public Warrant”). On September 19, 2019, in connection with the underwriters’ exercise of the over-allotment option in full, the Company sold an additional 3,000,000 Units at a price of $10.00 per Unit. Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at an exercise price of $11.50 per whole share (see Note 7).

Private Placement

Private Placement	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Private Placement	Note 4 — Private Placement Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 5,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $5,500,000. On September 19, 2019, in connection with the underwriters’ exercise of the over-allotment option in full, the Company sold an additional 600,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account.	NOTE 5 — PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 5,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $5,500,000. On September 19, 2019, in connection with the underwriters’ exercise of the over-allotment option in full, the Company sold an additional 600,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, certain of the proceeds from the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

Fair Value Measurement

Fair Value Measurement	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurement	Note 5 — Fair Value Measurement The Company follows the guidance in ASC 820, Fair Value Measurement, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2020 and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, December 31, Description Level 2021 2020 Assets: Marketable securities held in Trust Account 1 $ 231,913,996 $ 232,196,027 Liabilities: Public warrant liability 1 $ 40,710,000 $ 43,470,000 Private placement warrant liability 2 $ 25,376,000 $ 24,644,000 The Public Warrants as of March 31, 2021 and December 31, 2020 are classified as Level 1 due to the use of an observable market quote in an active market under the ticker ASTSW. The Private Warrants are valued using a Black-Scholes-Merton Model. As of March 31, 2021 and December 31, 2020 the Private Warrants are classified as Level 2 as the transfer of Private Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private Placement Warrants having substantially the same terms as the Public Warrants. For this reason, the Company determined that the volatility of each Private Warrant is equivalent to that of each Public Warrant. The Company’s Black-Scholes-Merton model to value Private Warrants required the use of the following subjective assumptions inputs: ● The risk-free interest rate assumption was based on the five-year U.S. Treasury rate, which was commensurate with the contractual term of the Warrants, which expire on the earlier of (i) five years after the completion of the initial business combination and (ii) upon redemption or liquidation. An increase in the risk-free interest rate, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. ● The expected term was determined to be one year, as the Warrants become exercisable on the later of (i) 30 days after the completion of a business combination and (ii) 12 months from the Initial Public Offering date. An increase in the expected term, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. ● The expected volatility assumption was based on the implied volatility of the Company’s publicly-traded warrants.	NOTE 6 — FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820, Fair Value Measurement, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2020 and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: December 31, December 31, Description Level 2020 2019 Assets: Marketable securities held in Trust Account 1 $ 232,196,027 $ 231,214,831 Liabilities: Public warrant liability 1 $ 43,470,000 $ 10,350,000 Private placement warrant liability 2 $ 24,644,000 $ 5,612,000 Initial Measurement The Company established the initial fair value for the Public Warrants in September 2019 using a Monte Carlo simulation model. The Company established the initial fair value for the Private Warrants in September 2019 using a Black-Scholes-Merton model. The key inputs into the Monte Carlo simulation model for the Public Warrants and Black-Scholes-Merton model for the Private Warrants were as follows at initial measurement: September 2019 (Initial Measurement) Exercise price $ 11.50 Fair value of Units $ 10.04 Contractual term (years) 6 Volatility (annual) 11.00 % Risk-free rate 1.62 % The Company’s use of a Monte Carlo simulation model and Black-Scholes-Merton model required the use of subjective assumptions: ● The risk-free interest rate assumption was based on the five-year U.S. Treasury rate, which was commensurate with the contractual term of the Warrants, which expire on the earlier of (i) five years after the completion of the initial business combination and (ii) upon redemption or liquidation. An increase in the risk-free interest rate, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. ● The expected term was determined to be one year, as the Warrants become exercisable on the later of (i) 30 days after the completion of a business combination and (ii) 12 months from the Initial Public Offering date. An increase in the expected term, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. ● The expected volatility assumption was based on the implied volatility from a set of comparable publicly-traded warrants as determined based on the size and proximity of other similar business combinations. An increase in the expected volatility, in isolation, would result in an increase in the fair value measurement of the warrant liabilities and vice versa. ● The fair value of the Units, which each consist of one Class A ordinary share and one-half of one Public Warrant, represents the closing price on the measurement date. Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of December 31, 2020 and 2019 is classified as Level 1 due to the use of an observable market quote in an active market under the ticker ASTSW. As the transfer of Private Warrants to anyone outside of a small group of individuals who are permitted transferees would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the volatility of each Private Warrant is equivalent to that of each Public Warrant. As such, the Private Warrants are classified as Level 2. The following table presents the changes in the fair value of warrant liabilities: Public warrant liability Private placement warrant liability Warrant liabilities Balance at May 28, 2019 (inception) $ - $ - $ - Initial measurement 8,395,000 4,514,000 12,909,000 Changes in fair value 1,955,000 1,098,000 3,053,000 Balance at December 31, 2019 10,350,000 5,612,000 15,962,000 Changes in fair value 33,120,000 19,032,000 52,152,000 Balance at December 31, 2020 43,470,000 24,644,000 68,114,000 Due to the use of quoted prices in an active market (Level 1) and the use of observable inputs for similar assets or liabilities (Level 2) to measure the fair values of the Public Warrants and Private Warrants, respectively, subsequent to initial measurement, the Company had transfers out of Level 3 totaling $13,085,000 during the period from September 2019, through December 31, 2019.

Related Party Transactions

Related Party Transactions	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	Note 6 — Related Party Transactions Founder Shares In June 2019, the Sponsor purchased 3,593,750 shares of Class B common stock (the “Founder Shares”) for an aggregate purchase price of $25,000. On August 23, 2019, the Company effected a stock split resulting in an increase on the total number of shares of Class B common stock outstanding from 3,593,750 to 5,750,000 shares. Subsequent to such stock split, in August 2019, the Sponsor transferred 10,000 Founder Shares to each of Mr. Bradley, the Company’s Chief Financial Officer and, and Messrs. Gannon, Ginsberg and Mazer, the Company’s independent directors. The 5,750,000 Founder Shares included an aggregate of up to 750,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor will own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor does not purchase any Public Shares in the Initial Public Offering). As a result of the underwriters’ election to fully exercise their over-allotment option, 750,000 Founder Shares are no longer subject to forfeiture. The Founder Shares will automatically convert into shares of Class A common stock upon completion of a Business Combination on a one-for-one basis, subject to certain adjustments, as described in Note 8. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note – Related Party On June 20, 2019, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note is non-interest bearing and payable on the earlier of December 31, 2019 or the completion of the Initial Public Offering. At September 30, 2019, the outstanding balance under the Promissory Note in the aggregate amount of $155,093 was repaid. Administrative Support Agreement The Company entered into an agreement whereby, commencing on September 13, 2019 through the earlier of the Company’s completion of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support services. For the three months ended March 31, 2021 and 2020, the Company incurred $30,000 and $30,000, respectively, in fees for these services. As of March 31, 2021 and December 31, 2020, $10,000 and $30,000 is included in accounts payable and accrued expenses in the accompanying condensed balance sheets, respectively. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. On January 28, 2021 and on February 18, 2021, the Sponsor agreed to loan the Company $200,000 and $500,000 for an aggregate of $700,000, respectively. The promissory notes (“Notes”) are provided to cover certain expenses related to the business combination. The Notes are non-interest bearing and payable on the earlier of June 30, 2021 or the completion of the Business Combination. As of March 31, 2021, the Company borrowed $600,000 under the Notes.	NOTE 7 — RELATED PARTY TRANSACTIONS Founder Shares In June 2019, the Sponsor purchased 3,593,750 shares of Class B common stock (the “Founder Shares”) for an aggregate purchase price of $25,000. On August 23, 2019, the Company effected a stock split resulting in an increase on the total number of shares of Class B common stock outstanding from 3,593,750 to 5,750,000 shares. Subsequent to such stock split, in August 2019, the Sponsor transferred 10,000 Founder Shares to each of Mr. Bradley, the Company’s Chief Financial Officer and, and Messrs. Gannon, Ginsberg and Mazer, the Company’s independent directors. The 5,750,000 Founder Shares included an aggregate of up to 750,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor will own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering (assuming the Sponsor does not purchase any Public Shares in the Initial Public Offering). As a result of the underwriters’ election to fully exercise their over-allotment option, 750,000 Founder Shares are no longer subject to forfeiture. The Founder Shares will automatically convert into shares of Class A common stock upon consummation of a Business Combination on a one-for-one basis, subject to certain adjustments, as described in Note 8. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Promissory Note — Related Party On June 20, 2019, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note is non-interest bearing and payable on the earlier of December 31, 2019 or the completion of the Initial Public Offering. At September 30, 2019, the outstanding balance under the Promissory Note in the aggregate amount of $155,093 was repaid. Administrative Support Agreement The Company entered into an agreement whereby, commencing on September 13, 2019 through the earlier of the Company’s consummation of a Business Combination and its liquidation, the Company will pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support services. For the year ended December 31, 2020 and for the period from May 28, 2019 (inception) through December 31, 2019, the Company incurred $120,000 and $35,000 in fees for these services, respectively. As of December 31, 2020, and 2019, $30,000 and $35,000 is included in accounts payable and accrued expenses in the accompanying balance sheets, respectively. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

Commitments

Commitments	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 7 — Commitments Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration and Stockholder Rights Pursuant to a registration rights and stockholder agreement entered into on September 13, 2019, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration and stockholder rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters of the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. Up to 40% of such amount (or $3,220,000) may be paid at the sole discretion of the Company’s management team to the underwriters in the allocations determined by the management team and/or to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in completing a Business Combination. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes a Business Combination, subject to the terms of the underwriting agreement. Equity Purchase Agreement On December 15, 2020, the Company entered into an equity purchase agreement (the “Equity Purchase Agreement”) with AST & Science LLC, a Delaware limited liability company (“AST”), the existing equityholders of AST (the “Existing Equityholders”), the Sponsor and Abel Avellan (“Existing Equityholder Representative”) in his capacity as Existing Equityholder Representative. The transactions contemplated by the Equity Purchase Agreement are referred to herein as the “AST Business Combination.” Following the closing of the AST Business Combination (the “Closing”), the Company will be organized as an umbrella partnership-C corporation structure, in which substantially all of the operating assets of AST’s business will be held by AST, and the Company’s only assets will be its equity interests in AST. The Company will be renamed AST SpaceMobile, Inc. (“SpaceMobile”) at Closing. At the Closing, the Company will (i) amend and restate its existing Certificate of Incorporation (the “A&R Certificate of Incorporation”) to, among other things, (a) change the name of the Company to AST SpaceMobile, Inc., (b) convert all then-outstanding Founder Shares, excluding any Forfeited Founder Shares into shares of Class A common stock, par value $0.0001 per share, of SpaceMobile (“Class A Common Stock”) and (c) authorize the issuance of Class B common stock, par value $0.0001 per share, of SpaceMobile (“Class B Common Stock”) and Class C common stock, par value $0.0001 per share, of SpaceMobile (“Class C Common Stock”) and (ii) replace the Amended and Restated By-Laws of the Company (the “Existing Bylaws”), by adopting the Bylaws of AST SpaceMobile, Inc. (the “SpaceMobile Bylaws”). Concurrently with the Equity Purchase Agreement, the Company entered into various subscription agreements (the “Subscription Agreements”) with certain third-party investors wherein the investors have committed to make private investments in public equity (“PIPE”) in the form of Class A Common Stock in an aggregate amount of $230 million (the “PIPE Investment”). In exchange for the PIPE Investment, these “PIPE Investors” will receive an aggregate of 23 million shares of Class A Common Stock. The Equity Purchase Agreement contains customary representations, warranties and covenants by the parties thereto and the Closing is subject to certain conditions as further described in the Equity Purchase Agreement. Upon closing the business combination, the Company and AST anticipate incurring transaction costs to investment bankers, attorneys and other service providers. In anticipation of a proxy vote to approve the AST Business Combination, certain PIPE Investors deposited $50,000,000 into the Company’s operating account. As such, these funds are presented as a liability (Deposit from investors) within the balance sheet as an offset to the increase in cash.	NOTE 8 — COMMITMENTS Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration and Stockholder Rights Pursuant to a registration rights and stockholder agreement entered into on September 13, 2019, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration and stockholder rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Company’s Class A common stock). The holders of the majority of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters of the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. Up to 40% of such amount (or $3,220,000) may be paid at the sole discretion of the Company’s management team to the underwriters in the allocations determined by the management team and/or to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in consummating a Business Combination. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes a Business Combination, subject to the terms of the underwriting agreement. Equity Purchase Agreement On December 15, 2020, the Company entered into an equity purchase agreement (the “Equity Purchase Agreement”) with AST & Science LLC, a Delaware limited liability company (“AST”), the existing equityholders of AST (the “Existing Equityholders”), the Sponsor and Abel Avellan (“Existing Equityholder Representative”) in his capacity as Existing Equityholder Representative. The transactions contemplated by the Equity Purchase Agreement are referred to herein as the “AST Business Combination.” Following the closing of the AST Business Combination (the “Closing”), the Company will be organized as an umbrella partnership-C corporation structure, in which substantially all of the operating assets of AST’s business will be held by AST, and the Company’s only assets will be its equity interests in AST. The Company will be renamed AST SpaceMobile, Inc. (“SpaceMobile”) at Closing. At the Closing, the Company will (i) amend and restate its existing Certificate of Incorporation (the “A&R Certificate of Incorporation”) to, among other things, (a) change the name of the Company to AST SpaceMobile, Inc., (b) convert all then-outstanding Founder Shares, excluding any Forfeited Founder Shares into shares of Class A common stock, par value $0.0001 per share, of SpaceMobile (“Class A Common Stock”) and (c) authorize the issuance of Class B common stock, par value $0.0001 per share, of SpaceMobile (“Class B Common Stock”) and Class C common stock, par value $0.0001 per share, of SpaceMobile (“Class C Common Stock”) and (ii) replace the Amended and Restated By-Laws of the Company (the “Existing Bylaws”), by adopting the Bylaws of AST SpaceMobile, Inc. (the “SpaceMobile Bylaws”). Concurrently with the Equity Purchase Agreement, the Company entered into various subscription agreements (the “Subscription Agreements”) with certain third-party investors (the “PIPE Investors”) pursuant to which the PIPE Investors have committed to make private investments in public equity in the form of Class A Common Stock in an aggregate amount of $230 million (the “PIPE Investment”). In exchange for the PIPE Investment, the PIPE Investors will receive an aggregate of 23 million shares of Class A Common Stock. The Equity Purchase Agreement contains customary representations, warranties and covenants by the parties thereto and the Closing is subject to certain conditions as further described in the Equity Purchase Agreement. Upon closing the business combination, the Company and AST anticipate incurring transaction costs to investment bankers, attorneys and other service providers.

Stockholders' Equity

Stockholders' Equity	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Stockholders' Equity	Note 8 — Stockholders’ Equity Preferred Stock Class A Common Stock Class B Common Stock Holders of Class A common stock and Class B common stock will vote together as a single class on all matters submitted to a vote of stockholders except as required by law; provided that only holders of shares of Class B common stock have the right to vote on the election of the Company’s directors prior to the initial Business Combination. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.	NOTE 9 — STOCKHOLDERS’ EQUITY Preferred Stock Class A Common Stock Class B Common Stock Holders of Class A common stock and Class B common stock will vote together as a single class on all matters submitted to a vote of stockholders except as required by law; provided that only holders of shares of Class B common stock have the right to vote on the election of the Company’s directors prior to the initial Business Combination. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as- converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B common stock into an equal number of shares of Class A common stock, subject to adjustment as provided above, at any time.

Warrant Liabilities

Warrant Liabilities	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Warrants and Rights Note Disclosure [Abstract]
Warrant Liabilities	Note 9 — Warrant Liabilities Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless the Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that, as soon as practicable, but in no event later than fifteen (15) business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60 th Once the warrants become exercisable, the Company may redeem the Public Warrants: ● In whole and not in part; ● At a price of $0.01 per warrant; ● Upon a minimum of 30 days’ prior written notice of redemption; and ● If, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceed, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The warrants contain a settlement alternative which is triggered upon the occurrence of a tender, exchange or redemption offer which has been made to and accepted by more than 50% of the outstanding shares of common stock (other than a tender, exchange, or redemption offer made by the Company in connection with the redemption rights previously discussed). Upon the occurrence of such an event (the “Alternative Issuance”), the holders of the warrants shall be entitled to receive the highest amount of cash, securities, or other property to which such holder would have been entitled as a stockholder if the holder of the warrants had exercised the warrants prior to the expiration of such tender, exchange, or redemption offer and accepted such offer. If an Alternative Issuance were to occur in which a cash tender offer is made by a third party and accepted by 50% or more of outstanding shares of common stock, the warrants would be net cash settled, in an event that is outside of the Company’s control, and for which not all holders of the underlying shares also would receive cash (assuming not all shareholders accepted the tender offer). The presence of this potential settlement alternative precludes the Company from classifying the warrants within stockholders’ equity, regardless of the likelihood of such an event occurring. As of March 31, 2021 and December 31, 2020, the Company recorded warrant liabilities of $66,086,000 and $68,114,000, respectively, in the balance sheets. For the three months ended March 31, 2021 and 2020, the Company recognized a gain on the change in the fair value of the warrant liabilities of $2,028,000 and $6,925,000, respectively, in the statements of operations.	NOTE 10 — WARRANT LIABILITIES Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless the Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that, as soon as practicable, but in no event later than fifteen (15) business days, after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. Once the warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceed, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The warrants contain a settlement alternative which is triggered upon the occurrence of a tender, exchange or redemption offer which has been made to and accepted by more than 50% of the outstanding shares of common stock (other than a tender, exchange, or redemption offer made by the Company in connection with the redemption rights previously discussed). Upon the occurrence of such an event (the “Alternative Issuance”), the holders of the warrants shall be entitled to receive the highest amount of cash, securities, or other property to which such holder would have been entitled as a stockholder if the holder of the warrants had exercised the warrants prior to the expiration of such tender, exchange, or redemption offer and accepted such offer. If an Alternative Issuance were to occur in which a cash tender offer is made by a third party and accepted by 50% or more of outstanding shares of common stock, the warrants would be net cash settled, in an event that is outside of the Company’s control, and for which not all holders of the underlying shares also would receive cash (assuming not all shareholders accepted the tender offer). The presence of this potential settlement alternative precludes the Company from classifying the warrants within stockholders’ equity, regardless of the likelihood of such an event occurring. As of the issuance of the public warrants in September 2019 in connection with the offering, the Company recorded the public warrants at fair value of $8,395,000 with the remaining consideration received in the offering allocated to stockholders’ equity. The Company incurred $13,260,927 in issuance costs associated with the offering, of which $484,024 was allocated to the public warrants and expensed in the statement of operations in 2019. The remaining issuance costs were allocated to the stockholders’ equity component of the offering and recorded as an offset to additional paid-in capital. As of the issuance of the private placement warrants in September 2019, the Company recorded the warrants at a fair value of $4,514,000, with the difference of $1,586,000 between the issuance price and the fair value, recorded as a capital contribution to additional paid-in capital. As of December 31, 2020 and 2019, the Company recorded warrant liabilities of $68,114,000 and $15,962,000, respectively, in the balance sheets. For the year ended December 31, 2010 and for the period from May 28, 2019 through December 31, 2019, the Company recognized a loss on the change in the fair value of the warrant liabilities of $52,152,000 and $3,053,000, respectively, in the statements of operations.

Income Tax

Income Tax	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Income Tax	NOTE 11 — INCOME TAX The Company’s net deferred tax liability are as follows: Year Ended December 31, For the Period from May 28, December 31, Deferred tax liability Unrealized gain on marketable securities $ (9,680 ) $ (3,611 ) Total deferred tax liability (9,680 ) (3,611 ) Valuation Allowance — — Deferred tax liability, net of allowance $ (9,680 ) $ (3,611 ) The provision for income taxes consists of the following: Year Ended December 31, For the Period from Federal Current $ 159,877 $ 170,684 Deferred State and Local 6,069 3,611 Current — — Deferred — — Change in valuation allowance — — Income tax provision $ 165,946 $ 174,295 As of December 31, 2020 and 2019, the Company had did not have any of U.S. federal and state net operating loss carryovers available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: As of December 31, 2020 2019 Statutory federal income tax rate 21.0 % 21.0 % Change in fair value of warrant liabilities (21.1 %) (27.4 %) Business Combination expenses (0.2 %) 0.0 % Income tax provision (0.3 %) (6.4 %) The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company’s tax returns for the year ended December 31, 2020 and 2019 remain open and subject to examination. The Company considers Texas to be a significant state tax jurisdiction.

Subsequent Events

Subsequent Events	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 10 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On April 6, 2021, the Closing Date, NPA completed the previously announced business combination pursuant to that certain Equity Purchase Agreement, by and among NPA, AST, the existing equityholders of AST, New Providence Acquisition Management LLC, a Delaware limited liability company (“Sponsor”), and Abel Avellan. As contemplated by the Equity Purchase Agreement (a) NPA was appointed as the managing member of AST and AST became a subsidiary of NPA; (b) NPA changed its name to “AST SpaceMobile, Inc.”; (c) immediately prior to the closing of the Business Combination, all then-outstanding shares of Class B common stock, par value $0.0001 per share, of NPA (“NPA Class B Common Stock”) held by Sponsor (the “Sponsor Stock”) converted into shares of Class A common stock, par value $0.0001 per share, of NPA (“NPA Class A Common Stock”) immediately prior to the Business Combination; (d) each share of NPA Class A Common Stock, including those converted as described in (c) above, was converted into one share of Class A common stock, par value $0.0001 per share, of the Company (“Class A Common Stock”), and each warrant of NPA (an “NPA Warrant”) was converted into one warrant of the Company (a “Warrant”); (e) AST restructured its capitalization, appointed the Company as its managing member and issued to the Company 51,729,704 units of ownership interest in AST (the “AST Common Units”), which entitle the holder to the distributions, allocations, and other rights under the Fifth Amended and Restated Limited Liability Company Operating Agreement of AST (the “A&R Operating Agreement”), in exchange for which AST received approximately $227.0 million remaining in NPA’s trust account following (i) the $4.8 million payment of deferred underwriting commissions (ii) $0.2 million of redemptions made in connection with NPA’s special meeting of stockholders relating to the transactions contemplated by the Equity Purchase Agreement (the “Special Meeting”) and NPA’s annual meeting of stockholders to approve, among other things, a charter amendment to extend the date by which it had to complete an initial business combination and (iii) the repayment of a $0.6 million related party loan between the Sponsor and NPA; (f) AST issued to the Company warrants to purchase up to 17,600,000 AST Common Units; (g); certain investors (the “PIPE Investors”) purchased 23,000,000 shares of Class A Common Stock; (h) the Company issued 51,636,922 shares of Class B common stock, par value $0.0001 per share, of the Company, which carries one vote per share but no economic rights (“Class B Common Stock”) to the Existing AST Equityholders (other than Avellan); and (i) the Company issued 78,163,078 shares of Class C common stock, par value $0.0001 per share, of the Company, which carries ten votes per share but no economic rights (“Class C Common Stock”) to Avellan (the transactions referred to in clauses (a) through (i), collectively, the “Business Combination”). As a result of the Business Combination, the Company is organized in an “Up-C” structure in which substantially all of the operating assets of AST’s business are held by AST, and the Company’s only assets are its equity interests in AST. As of the open of trading on April 7, 2021, the Class A Common Stock and Warrants of AST SpaceMobile, Inc., formerly those of NPA, began trading on The Nasdaq Capital Market (“Nasdaq”) as “ASTS” and “ASTSW,” respectively. In connection with the Business Combination, holders of 8,460 shares of NPA Class A Common Stock exercised their rights to redeem those shares for cash at an approximate price of $10.09 per share, for an aggregate of approximately $85,348, which was paid to such holders on the Closing Date.	NOTE 12 — SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On January 28, 2021 and on February 18, 2021, the Sponsor agreed to loan the Company $200,000 and $500,000, respectively, for an aggregate of $700,000. The promissory notes (“Notes”) are provided to cover certain expenses related to the business combination. The Notes are non- interest bearing and payable on the earlier of June 30, 2021 or the completion of the Business Combination. As of February 26, 2021, the Company borrowed $300,000 under the Notes.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2020 as filed with the SEC on May 6, 2021, which contains the audited financial statements and notes thereto. The interim results for the three months ended March 31, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.	Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.	Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2021 and December 31, 2020.	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020 and, 2019.
Cash and Marketable Securities Held in Trust Account	Cash and Marketable Securities Held in Trust Account At March 31, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. During the three months ended March 31, 2021, the Company withdrew $303,228 of interest earned on the Trust Account to pay its franchise and income taxes.	Cash and Marketable Securities Held in Trust Account At December 31, 2020 and, 2019, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. During the year ended December 31, 2020, the Company withdrew $500,620 of interest earned on the Trust Account to pay its franchise and income taxes.
Class A common Stock Subject to Possible Redemption	Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.	Class A common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC 480, Distinguishing Liabilities from Equity (“ASC 480”). Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheets.
Warrant Liabilities	Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in the ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). Management’s assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period-end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, they are recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, they are recorded at their initial fair value on the date of issuance and subject to remeasurement each balance sheet date with changes in the estimated fair value of the warrants to be recognized as a non-cash gain or loss in the statement of operations.	Warrant Liabilities The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in the ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). Management’s assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, whether they meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period-end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, they are recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, they are recorded at their initial fair value on the date of issuance and subject to remeasurement each balance sheet date with changes in the estimated fair value of the warrants to be recognized as a non-cash gain or loss in the statement of operations.
Income Taxes	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.	Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, Income Taxes (“ASC 740”). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020 and 2019. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, President Trump signed the Coronavirus Aid, Relief, and Economic Security “CARES” Act into law. The CARES Act includes several significant business tax provisions that, among other things, would eliminate the taxable income limit for certain net operating losses (“NOL) and allow businesses to carry back NOLs arising in 2018, 2019 and 2020 to the five prior years, suspend the excess business loss rules, accelerate refunds of previously generated corporate alternative minimum tax credits, generally loosen the business interest limitation under IRC section 163(j) from 30 percent to 50 percent among other technical corrections included in the Tax Cuts and Jobs Act tax provisions. The Company does not believe that the CARES Act will have a significant impact on Company’s financial position or statement of operations.
Net Income Per Common Share	Net Income Per Common Share Net income per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at March 31, 2021 and 2020, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic income per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 17,600,000 shares of common stock. As a result, diluted income per common share is the same as basic income per common share for the periods presented.	Net Loss Per Common Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at December 31, 2020 and 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic loss per share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. The Company has not considered the effect of warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 17,600,000 shares of common stock. As a result, diluted loss per common share is the same as basic loss per common share for the periods presented.
Reconciliation of Net Income Per Common Share	Reconciliation of Net Income Per Common Share The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted income per common share is calculated as follows: For the Three Months Ended March 31 2021 March 31 2020 Net income 597,052 7,772,252 Less: Income attributable to common stock subject to possible redemption 27,616 890,626 Adjusted net income 569,436 6,881,626 Weighted average common shares subject to possible redemption outstanding, basic and diluted 14,922,915 20,157,878 Basic and diluted income per common share subject to possible redemption 0.00 0.04 Weighted average non-redeemable common shares outstanding, basic and diluted 13,827,085 8,592,122 Basic and diluted net loss per non-redeemable common share 0.04 0.80	Reconciliation of Net Loss Per Common Share The Company’s net income (loss) is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted net loss per common share is calculated as follows: For the year Ended December 31, 2020 For the Period from May 28, 2019 (inception) through December 31, 2019 Net loss $ (51,960,823 ) $ (2,881,345 ) Less: Income attributable to common stock subject to possible redemption (723,829 ) (848,726 ) Adjusted net loss (52,684,652 ) (3,730,070 ) Weighted average common shares subject to possible redemption outstanding, basic and diluted 20,151,440 10,207,641 Basic and diluted income per common share subject to possible redemption 0.04 0.08 Weighted average shares outstanding, basic and diluted 8,598,542 6,111,484 Basic and diluted net loss per non-redeemable common share $ (6.13 ) $ (0.61 )
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments U.S. GAAP requires disclosing the fair value of financial instruments to the extent practicable for financial instruments which are recognized or unrecognized in the balance sheet. The fair value of the financial instruments disclosed herein is not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. In assessing the fair value of financial instruments, the Company uses a variety of methods and assumptions, which are based on estimates of market conditions and risks existing at the time. For certain instruments, including cash, accounts receivable, accounts payable, and accrued expenses, it was estimated that the carrying amount approximated fair value because of the short maturities of these instruments.	Fair Value of Financial Instruments U.S. GAAP requires disclosing the fair value of financial instruments to the extent practicable for financial instruments which are recognized or unrecognized in the balance sheet. The fair value of the financial instruments disclosed herein is not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. In assessing the fair value of financial instruments, the Company uses a variety of methods and assumptions, which are based on estimates of market conditions and risks existing at the time. For certain instruments, including cash, accounts receivable, accounts payable, and accrued expenses, it was estimated that the carrying amount approximated fair value because of the short maturities of these instruments.
Recent Accounting Standards	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.	Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Restatement of Financial Stat_2

Restatement of Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Summary of Impact of the Restatement	Impact of the Restatement – 2020 Balance Sheets December 31, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 68,114,000 $ 68,114,000 Total liabilities 8,693,966 68,114,000 76,807,966 Class A common stock subject to possible redemption 218,710,925 (68,113,997 ) 150,596,928 Class A common stock 133 808 941 Addition paid-in capital 4,152,440 55,688,213 59,840,653 Retained earnings (accumulated deficit) 846,856 (55,689,024 ) (54,842,168 ) Total stockholders’ equity (deficit) 5,000,004 (3 ) 5,000,001 Statements of Operations For the Year Ended December 31, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (52,152,000 ) $ (52,152,000 ) Other income (expense), net 1,481,816 (52,152,000 ) (50,670,184 ) Net income (loss) 191,177 (52,152,000 ) (51,960,823 ) Weighted average shares outstanding, basic and diluted 7,008,667 1,589,875 8,598,542 Basic and diluted net loss per common share $ (0.12 ) $ (6.01 ) $ (6.13 ) Statements of Cash Flows For the Year Ended December 31, 2020 As Reported Adjustments As Revised Net income (loss) $ 191,177 $ (52,152,000 ) $ (51,960,823 ) Change in fair value of warrant liabilities - 52,152,000 52,152,000 Non-cash investing and financing activities: Change in value of shares subject to redemption 191,177 (52,152,000 ) (51,960,823 ) Balance Sheets September 30, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 21,357,000 $ 21,357,000 Total liabilities 8,310,507 21,357,000 29,667,507 Class A common stock subject to possible redemption 219,259,970 (21,356,993 ) 197,902,977 Class A common stock 127 338 465 Additional paid-in capital 3,603,401 8,931,679 12,535,080 Retained earnings (accumulated deficit) 1,395,905 (8,932,024 ) (7,536,119 ) Total stockholders’ equity (deficit) 5,000,008 (7 ) 5,000,001 Statements of Operations Three Months Ended September 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (3,696,000 ) $ (3,696,000 ) Other income (expense), net 83,140 (3,696,000 ) (3,612,860 ) Net income (loss) (55,049 ) (3,696,000 ) (3,751,049 ) Weighted average shares outstanding, basic and diluted 7,007,989 1,750,840 8,758,829 Basic and diluted net loss per common share $ (0.01 ) $ (0.42 ) $ (0.43 ) Statements of Operations Nine Months Ended September 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (5,395,000 ) $ (5,395,000 ) Other income (expense), net 1,429,005 (5,395,000 ) (3,965,995 ) Net income (loss) 740,226 (5,395,000 ) (4,654,774 ) Weighted average shares outstanding, basic and diluted 5,307,098 3,111,439 8,418,537 Basic and diluted net loss per common share $ (0.02 ) $ (0.64 ) $ (0.66 ) Statements of Cash Flows Nine Months Ended September 30, 2020 As Reported Adjustments As Revised Net income (loss) $ 740,226 $ (5,395,000 ) $ (4,654,774 ) Change in fair value of warrant liabilities - 5,395,000 5,395,000 Non-cash investing and financing activities: Change in value of shares subject to redemption 740,222 (4,491,271 ) (3,751,049 ) Balance Sheets June 30, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 17,661,000 $ 17,661,000 Total liabilities 8,256,307 17,661,000 25,917,307 Class A common stock subject to possible redemption 219,315,022 (17,660,996 ) 201,654,026 Class A common stock 126 301 427 Additional paid-in capital 3,548,350 5,235,719 8,784,069 Retained earnings (accumulated deficit) 1,450,954 (5,236,024 ) (3,785,070 ) Total stockholders’ equity (deficit) 5,000,005 (4 ) 5,000,001 Statements of Operations Three Months Ended June 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (8,624,000 ) $ (8,624,000 ) Other income (expense), net 88,138 (8,624,000 ) (8,535,862 ) Net income (loss) (51,977 ) (8,624,000 ) (8,675,977 ) Weighted average shares outstanding, basic and diluted 7,005,122 895,798 7,900,920 Basic and diluted net loss per common share $ (0.01 ) $ (1.09 ) $ (1.10 ) Statements of Operations Six Months Ended June 30, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ (1,699,000 ) $ (1,699,000 ) Other income (expense), net 1,345,865 (1,699,000 ) (353,135 ) Net income (loss) 795,275 (1,699,000 ) (903,725 ) Weighted average shares outstanding, basic and diluted 7,004,380 1,242,141 8,246,521 Basic and diluted net loss per common share $ (0.03 ) $ (0.19 ) $ (0.22 ) Statements of Cash Flows Six Months Ended June 30, 2020 As Reported Adjustments As Revised Net income (loss) $ 795,275 $ (1,699,000 ) $ (903,725 ) Change in fair value of warrant liabilities - 1,699,000 1,699,000 Non-cash investing and financing activities: Change in value of shares subject to redemption 795,274 (9,471,251 ) (8,675,977 ) Balance Sheets March 31, 2020 As Reported Adjustments As Revised Warrant liabilities $ - $ 9,037,000 $ 9,037,000 Total liabilities 8,548,277 9,037,000 17,585,277 Class A common stock subject to possible redemption 219,367,001 (9,036,998 ) 210,330,003 Class A common stock 126 215 341 Additional paid-in capital 3,496,371 (3,388,193 ) 108,178 Retained earnings 1,502,931 3,387,976 4,890,907 Total stockholders’ equity (deficit) 5,000,003 (2 ) 5,000,001 Statements of Operations Three Months Ended March 31, 2020 As Reported Adjustments As Revised Changes in fair value of warrant liabilities $ - $ 6,925,000 $ 6,925,000 Other income, net 1,257,727 6,925,000 8,182,727 Net income 847,252 6,925,000 7,772,252 Weighted average shares outstanding, basic and diluted 7,003,637 1,588,485 8,592,122 Basic and diluted net income (loss) per common share $ (0.01 ) $ 0.81 $ 0.80 Statements of Cash Flows Three Months Ended March 31, 2020 As Reported Adjustments As Revised Net income $ 847,252 $ 6,925,000 $ 7,772,252 Change in fair value of warrant liabilities - (6,925,000 ) (6,925,000 ) Non-cash investing and financing activities: Change in value of shares subject to redemption 847,253 6,924,999 7,772,252 Impact of the Restatement – 2019 Balance Sheets December 31, 2019 As Reported Adjustments As Revised Warrant liabilities $ - $ 15,962,000 $ 15,962,000 Total liabilities 8,319,433 15,962,000 24,281,433 Class A common stock subject to possible redemption 218,519,748 (15,961,997 ) 202,557,751 Class A common stock 125 284 409 Addition paid-in capital 4,343,625 3,536,737 7,880,362 Retained earnings (accumulated deficit) 655,679 (3,537,024 ) (2,881,345 ) Total stockholders’ equity (deficit) 5,000,004 (3 ) 5,000,001 Statements of Operations For the Period From May 28, 2019 (inception) through December 31, 2019 As Reported Adjustments As Revised Changes in fair value of warrant liabilities - (3,053,000 ) (3,053,000 ) Issuance costs allocated to warrant liabilities - (484,024 ) (484,024 ) Other income (expense), net 1,214,831 (3,537,024 ) (2,322,193 ) Net income (loss) 655,679 (3,537,024 ) (2,881,345 ) Weighted average shares outstanding, basic and diluted 6,075,732 35,752 6,111,484 Basic and diluted net loss per common share $ (0.04 ) $ (0.57 ) $ (0.61 ) Statements of Cash Flows For the Period From May 28, 2019 (inception) through December 31, 2019 As Reported Adjustments As Revised Operating Activities: Net income (loss) $ 655,679 $ (3,537,024 ) $ (2,881,345 ) Change in fair value of warrant liabilities - 3,053,000 3,053,000 Net cash used in operating activities (420,945 ) (484,024 ) (904,969 ) Financing Activities: Proceeds from sale of Units, net of underwriting discounts paid 225,400,000 484,024 225,884,024 Net cash provided by financing activities 230,914,073 484,024 231,398,097 Non-cash investing and financing activities: Initial classification of ordinary shares subject to redemption 217,862,910 (12,909,000 ) 204,953,910 Change in value of shares subject to redemption 656,838 (3,052,997 ) (2,396,159 ) Balance Sheets September 30, 2019 As Reported Adjustments As Revised Warrant liabilities $ - $ 13,085,000 $ 13,085,000 Total liabilities 8,125,774 13,085,000 21,210,774 Class A common stock subject to possible redemption 217,950,740 (13,085,000 ) 204,865,740 Class A common stock 122 253 375 Additional paid-in capital 4,912,636 659,771 5,572,407 Retained earnings (accumulated deficit) 86,668 (660,024 ) (573,356 ) Statements of Operations Three Months Ended September 30, 2019 As Reported Adjustments As Revised Changes in fair value of warrant liabilities - (176,000 ) (176,000 ) Issuance costs allocated to warrant liabilities - (484,024 ) (484,024 ) Other income (expense), net 205,420 (660,024 ) (454,604 ) Net income (loss) 87,761 (660,024 ) (572,263 ) Weighted average shares outstanding, basic and diluted 5,307,098 228,499 5,535,597 Basic and diluted net income (loss) per common share $ (0.02 ) $ (0.11 ) $ (0.13 ) Statements of Operations For the Period From May 28, 2019 (inception) through September 30, 2019 As Reported Adjustments As Revised Changes in fair value of warrant liabilities - (176,000 ) (176,000 ) Issuance costs allocated to warrant liabilities - (484,024 ) (484,024 ) Other income (expense), net 205,420 (660,024 ) (454,604 ) Net income (loss) 86,668 (660,024 ) (573,356 ) Weighted average shares outstanding, basic and diluted 5,274,301 (760,101 ) 4,514,200 Basic and diluted net income (loss) per common share $ (0.02 ) $ (0.14 ) $ (0.16 ) Statements of Cash Flows For the Period From May 28, 2019 (inception) through September 30, 2019 As Reported Adjustments As Revised Operating Activities: Net income (loss) $ 86,668 $ (660,024 ) $ (573,356 ) Change in fair value of warrant liabilities - 176,000 176,000 Net cash used in operating activities (208,689 ) (484,024 ) (692,713 ) Financing Activities: Proceeds from sale of Units, net of underwriting discounts paid 225,400,000 484,024 225,884,024 Net cash provided by financing activities 230,914,073 484,024 231,398,097 Non-cash investing and financing activities: Initial classification of ordinary shares subject to redemption 217,862,910 (12,908,991 ) 204,953,919 Change in value of shares subject to redemption 87,830 (176,009 ) (88,179 ) Balance Sheets September 13, 2019 As Reported Adjustments As Revised Warrant liabilities $ - $ 11,370,000 $ 11,370,000 Total liabilities 8,084,093 11,370,000 19,454,093 Class A common stock subject to possible redemption 188,912,910 (11,369,991 ) 177,542,919 Class A common stock 111 114 225 Additional paid-in capital 5,000,477 423,676 5,424,153 Retained earnings (accumulated deficit) (1,153 ) (423,799 ) (424,952 ) Total stockholders’ equity (deficit) 5,000,010 (9 ) 5,000,001

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Schedule of Basic and Diluted Net Loss Per Common Share	Accordingly, basic and diluted income per common share is calculated as follows: For the Three Months Ended March 31 2021 March 31 2020 Net income 597,052 7,772,252 Less: Income attributable to common stock subject to possible redemption 27,616 890,626 Adjusted net income 569,436 6,881,626 Weighted average common shares subject to possible redemption outstanding, basic and diluted 14,922,915 20,157,878 Basic and diluted income per common share subject to possible redemption 0.00 0.04 Weighted average non-redeemable common shares outstanding, basic and diluted 13,827,085 8,592,122 Basic and diluted net loss per non-redeemable common share 0.04 0.80	The Company’s net income (loss) is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted net loss per common share is calculated as follows: For the year Ended December 31, 2020 For the Period from May 28, 2019 (inception) through December 31, 2019 Net loss $ (51,960,823 ) $ (2,881,345 ) Less: Income attributable to common stock subject to possible redemption (723,829 ) (848,726 ) Adjusted net loss (52,684,652 ) (3,730,070 ) Weighted average common shares subject to possible redemption outstanding, basic and diluted 20,151,440 10,207,641 Basic and diluted income per common share subject to possible redemption 0.04 0.08 Weighted average shares outstanding, basic and diluted 8,598,542 6,111,484 Basic and diluted net loss per non-redeemable common share $ (6.13 ) $ (0.61 )

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on a Recurring Basis	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2020 and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: March 31, December 31, Description Level 2021 2020 Assets: Marketable securities held in Trust Account 1 $ 231,913,996 $ 232,196,027 Liabilities: Public warrant liability 1 $ 40,710,000 $ 43,470,000 Private placement warrant liability 2 $ 25,376,000 $ 24,644,000	The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2020 and 2019 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: December 31, December 31, Description Level 2020 2019 Assets: Marketable securities held in Trust Account 1 $ 232,196,027 $ 231,214,831 Liabilities: Public warrant liability 1 $ 43,470,000 $ 10,350,000 Private placement warrant liability 2 $ 24,644,000 $ 5,612,000
Schedule of Initial Measurement		The Company established the initial fair value for the Private Warrants in September 2019 using a Black-Scholes-Merton model. The key inputs into the Monte Carlo simulation model for the Public Warrants and Black-Scholes-Merton model for the Private Warrants were as follows at initial measurement: September 2019 (Initial Measurement) Exercise price $ 11.50 Fair value of Units $ 10.04 Contractual term (years) 6 Volatility (annual) 11.00 % Risk-free rate 1.62 %
Schedule of Changes in the Fair Value of Warrant Liabilities		The following table presents the changes in the fair value of warrant liabilities: Public warrant liability Private placement warrant liability Warrant liabilities Balance at May 28, 2019 (inception) $ - $ - $ - Initial measurement 8,395,000 4,514,000 12,909,000 Changes in fair value 1,955,000 1,098,000 3,053,000 Balance at December 31, 2019 10,350,000 5,612,000 15,962,000 Changes in fair value 33,120,000 19,032,000 52,152,000 Balance at December 31, 2020 43,470,000 24,644,000 68,114,000

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Schedule of Net Deferred Tax Liability	The Company’s net deferred tax liability are as follows: Year Ended December 31, For the Period from May 28, December 31, Deferred tax liability Unrealized gain on marketable securities $ (9,680 ) $ (3,611 ) Total deferred tax liability (9,680 ) (3,611 ) Valuation Allowance — — Deferred tax liability, net of allowance $ (9,680 ) $ (3,611 )
Schedule of Provision for Income Taxes	The provision for income taxes consists of the following: Year Ended December 31, For the Period from Federal Current $ 159,877 $ 170,684 Deferred State and Local 6,069 3,611 Current — — Deferred — — Change in valuation allowance — — Income tax provision $ 165,946 $ 174,295
Schedule of Federal Income Tax Rate	A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: As of December 31, 2020 2019 Statutory federal income tax rate 21.0 % 21.0 % Change in fair value of warrant liabilities (21.1 %) (27.4 %) Business Combination expenses (0.2 %) 0.0 % Income tax provision (0.3 %) (6.4 %)

Description of Organization a_2

Description of Organization and Business Operations (Details Narrative) - USD ($)	Sep. 19, 2019	Sep. 13, 2019	Sep. 30, 2019	Dec. 31, 2020	Dec. 31, 2019
Proceeds from initial public offering			$ 1,586,000	$ 13,260,927
Warrants exercise price					$ 11.50
Assets held trust account	$ 230,000,000
Initial Public Offering [Member]
Number of sale of stock share value		20,000,000
Proceeds from initial public offering		$ 200,000,000
Sale of stock, price per share		$ 10
Transaction cost	13,260,927
Underwriting fees	4,600,000
Deferred underwriting fees	8,050,000
Other offering costs	$ 610,927
Initial Public Offering [Member] | Third Party [Member]
Sale of stock, price per share	$ 10
Private Placement Warrants [Member]
Number of sale of stock share value	600,000	5,500,000
Proceeds from initial public offering	$ 30,600,000
Warrants exercise price	$ 1	$ 1
Proceeds from warrants		$ 5,500,000
Sale of stock, price per share	$ 1
Assets held trust account	$ 30,000,000
Over-Allotment Option [Member]
Number of sale of stock share value	3,000,000
Sale of stock, price per share	$ 10

Description of Organization a_3

Description of Organization and Business Operations (Details Narrative) (10-K) - USD ($)	Sep. 19, 2019	Sep. 13, 2019	Feb. 26, 2021	Sep. 30, 2019	Dec. 31, 2020	Mar. 31, 2021	Feb. 18, 2021	Jan. 28, 2021	Dec. 31, 2019
Proceeds from initial public offering				$ 1,586,000	$ 13,260,927
Warrants exercise price									$ 11.50
Assets held trust account	$ 230,000,000
Net tangible assets	$ 5,000,001
Seeking redemption rights percentage	15.00%
Operating bank accounts					131,151	$ 50,052,736			$ 493,128
Marketable securities held in Trust Account					232,196,027	$ 231,913,996			$ 231,214,831
Working capital deficit					337,484
Amount on deposit in the Trust Account					$ 2,196,027
Subsequent Event [Member]
Business combination, expenses			$ 300,000
Third Party [Member]
Business description	The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of trust assets, provided that such liability will not apply to any claims by a third party or prospective target
Sponsor [Member] | Subsequent Event [Member]
Agreed to loan							$ 500,000	$ 200,000
Aggregate of amount							$ 700,000	$ 700,000
Combination Period [Member]
Business description	The Company will have until March 15, 2021 (the "Combination Period") to consummate a Business Combination or obtain a Charter Extension from Shareholders. If the Company is unable to complete a Business Combination in the Combination Period or obtain a Charter Extension from Shareholders, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders' rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company's remaining stockholders and the Company's board of directors, dissolve and liquidate, subject in each case to the Company's obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company's warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
Initial Public Offering [Member]
Number of sale of stock share value		20,000,000
Gross proceeds from initial public offering		$ 200,000,000
Proceeds from initial public offering		$ 200,000,000
Sale of stock, price per share		$ 10
Transaction cost	$ 13,260,927
Underwriting fees	4,600,000
Deferred underwriting fees	8,050,000
Other offering costs	$ 610,927
Business description	The Company must complete an initial Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the initial Business Combination.
Business combination percentage of voting securities	50.00%
Private Placement Warrants [Member]
Number of sale of stock share value	600,000	5,500,000
Gross proceeds from initial public offering	$ 30,600,000
Proceeds from initial public offering	$ 30,600,000
Proceeds from warrants		$ 5,500,000
Warrants exercise price	$ 1	$ 1
Sale of stock, price per share	$ 1
Assets held trust account	$ 30,000,000
Over-Allotment Option [Member]
Number of sale of stock share value	3,000,000
Sale of stock, price per share	$ 10

Restatement of Financial Stat_3

Restatement of Financial Statements (Details Narrative) (10-K) - $ / shares	Dec. 31, 2019	Sep. 30, 2019
Warrant exercisable price per share	$ 11.50
Public Warrants [Member]
Aggregate warrants		11,500,000
Public Warrants [Member] | Class A Common Stock [Member]
Warrant exercisable price per share		$ 11.50
Private Warrants [Member]
Aggregate warrants		6,100,000
Private Warrants [Member] | Class A Common Stock [Member]
Warrant exercisable price per share		$ 11.50

Restatement of Financial Stat_4

Restatement of Financial Statements - Summary of Impact of the Restatement (Details) (10-K) - USD ($)	1 Months Ended	3 Months Ended					4 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2019	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2020	Sep. 13, 2019	May 27, 2019
Warrant liabilities	$ 13,085,000	$ 66,086,000	$ 21,357,000	$ 17,661,000	$ 9,037,000	$ 13,085,000	$ 13,085,000	$ 17,661,000	$ 15,962,000	$ 21,357,000	$ 68,114,000	$ 11,370,000
Total liabilities	21,210,774	125,994,263	29,667,507	25,917,307	17,585,277	21,210,774	21,210,774	25,917,307	24,281,433	29,667,507	76,807,966	19,454,093
Class A common stock subject to possible redemption	204,865,740	151,074,574	197,902,977	201,654,026	210,330,003	204,865,740	204,865,740	201,654,026	202,557,751	197,902,977	150,596,928	177,542,919
Class A common stock												225
Addition paid-in capital	5,572,407	59,243,594	12,535,080	8,784,069	108,178	5,572,407	5,572,407	8,784,069	7,880,362	12,535,080	59,840,653	5,424,153
Retained earnings (accumulated deficit)	(573,356)	(54,245,116)	(7,536,119)	(3,785,070)	4,890,907	(573,356)	(573,356)	(3,785,070)	(2,881,345)	(7,536,119)	(54,842,168)	(424,952)
Total stockholders' equity (deficit)		5,000,001	5,000,001	5,000,001	5,000,001			5,000,001	5,000,001	5,000,001	5,000,001	5,000,001
Change in fair value of warrant liabilities	(4,514,000)	2,028,000	(3,696,000)	(8,624,000)	6,925,000	(176,000)	(176,000)	(1,699,000)	(3,053,000)	(5,395,000)	(52,152,000)
Issuance costs allocated to warrant liabilities						(484,024)	(484,024)		(484,024)
Other income (expense), net		2,049,197	(3,612,860)	(8,535,862)	8,182,727	(454,604)	(454,604)	(353,135)	(2,322,193)	(3,965,995)	(50,670,184)
Net income (loss)		$ 597,052	$ (3,751,049)	$ (8,675,977)	$ 7,772,252	$ (572,263)	$ (573,356)	$ (903,725)	$ (2,881,345)	$ (4,654,774)	$ (51,960,823)
Weighted average shares outstanding, basic and diluted		13,827,085	8,758,829	7,900,920	8,592,122	5,535,597	4,514,200	8,246,521	6,111,484	8,418,537	8,598,542
Basic and diluted net loss per common share		$ 0.04	$ (0.43)	$ (1.10)	$ 0.8	$ (0.13)	$ 0.16	$ (0.22)	$ (0.61)	$ (0.66)	$ (6.13)
Change in value of shares subject to redemption		$ 477,646			$ 7,772,252		$ (88,179)	$ (8,675,977)	$ (2,396,159)	$ (3,751,049)	$ (51,960,823)
Net cash used in operating activities		(862,237)			(190,647)		(692,713)		(904,969)		(862,597)
Proceeds from sale of Units, net of underwriting discounts paid							225,884,024		225,884,024
Net cash provided by financing activities		50,480,594					231,398,097		231,398,097
Initial classification of ordinary shares subject to redemption							204,953,919		204,953,910
Class A Common Stock [Member]
Class A common stock	375	$ 948	$ 465	$ 427	341	$ 375	375	427	409	465	941
As Reported [Member]
Warrant liabilities
Total liabilities	8,125,774		8,310,507	8,256,307	8,548,277	8,125,774	8,125,774	8,256,307	8,319,433	8,310,507	8,693,966	8,084,093
Class A common stock subject to possible redemption	217,950,740		219,259,970	219,315,022	219,367,001	217,950,740	217,950,740	219,315,022	218,519,748	219,259,970	218,710,925
Class A common stock												111
Addition paid-in capital	4,912,636		3,603,401	3,548,350	3,496,371	4,912,636	4,912,636	3,548,350	4,343,625	3,603,401	4,152,440	5,000,477
Retained earnings (accumulated deficit)	86,668		1,395,905	1,450,954	1,502,931	86,668	86,668	1,450,954	655,679	1,395,905	846,856	(1,153)
Total stockholders' equity (deficit)			5,000,008	5,000,005	5,000,003			5,000,005	5,000,004	5,000,008	5,000,004	5,000,010
Change in fair value of warrant liabilities
Issuance costs allocated to warrant liabilities
Other income (expense), net			83,140	88,138	1,257,727	205,420	205,420	1,345,865	1,214,831	1,429,005	1,481,816
Net income (loss)			$ (55,049)	$ (51,977)	$ 847,252	$ 87,761	$ 86,668	$ 795,275	$ 655,679	$ 740,226	$ 191,177
Weighted average shares outstanding, basic and diluted			70,007,989	70,005,122	7,003,637	5,307,098	5,274,301	7,004,380	6,075,732	5,307,098	7,008,667
Basic and diluted net loss per common share			$ (0.01)	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)	$ (0.03)	$ (0.04)	$ (0.02)	$ (0.12)
Change in value of shares subject to redemption					$ 847,252		$ 87,830	$ 795,274	$ 656,838	$ 740,222	$ 191,177
Net cash used in operating activities							(208,689)		(420,945)
Proceeds from sale of Units, net of underwriting discounts paid							225,400,000		225,400,000
Net cash provided by financing activities							230,914,073		230,914,073
Initial classification of ordinary shares subject to redemption							217,862,910		217,862,910
As Reported [Member] | Class A Common Stock [Member]
Class A common stock subject to possible redemption												188,912,910
Class A common stock	122		$ 127	$ 126	126	$ 122	122	126	125	127	133
Adjustment [Member]
Warrant liabilities			21,357,000	17,661,000	9,037,000			17,661,000	15,962,000	21,357,000	68,114,000	11,370,000
Total liabilities	13,085,000		21,357,000	17,661,000	9,037,000	13,085,000	13,085,000	17,661,000	15,962,000	21,357,000	68,114,000	11,370,000
Class A common stock subject to possible redemption	(13,085,000)		(21,356,993)	(17,660,996)	(9,036,998)	(13,085,000)	(13,085,000)	(17,660,996)	(15,961,997)	(21,356,993)	(68,113,997)
Class A common stock												114
Addition paid-in capital	659,771		8,931,679	5,235,719	(3,388,193)	659,771	659,771	5,235,719	3,536,737	8,931,679	55,688,213	423,676
Retained earnings (accumulated deficit)	(660,024)		(8,932,024)	(5,236,024)	3,387,976	(660,024)	(660,024)	(5,236,024)	(3,537,024)	(8,932,024)	(55,689,024)	(423,799)
Total stockholders' equity (deficit)			(7)	(4)	(2)			(4)	(3)	(7)	(3)	(9)
Change in fair value of warrant liabilities			(3,696,000)	(8,624,000)	6,925,000	(176,000)	(176,000)	(1,699,000)	(3,053,000)	(5,395,000)	(52,152,000)
Issuance costs allocated to warrant liabilities						(484,024)	(484,024)		(484,024)
Other income (expense), net			(3,696,000)	(8,624,000)	6,925,000	(660,024)	(660,024)	(1,699,000)	(3,537,024)	(5,395,000)	(52,152,000)
Net income (loss)			$ (3,696,000)	$ (8,624,000)	$ 6,925,000	$ (660,024)	$ (660,024)	$ (1,699,000)	$ (3,537,024)	$ (5,395,000)	$ (52,152,000)
Weighted average shares outstanding, basic and diluted			1,750,840	895,798	1,588,485	228,499	(760,101)	1,242,141	35,752	3,111,439	1,589,875
Basic and diluted net loss per common share			$ (0.42)	$ (1.09)	$ 0.81	$ (0.11)	$ (0.14)	$ (0.19)	$ (0.57)	$ (0.64)	$ (6.01)
Change in value of shares subject to redemption					$ 6,924,999		$ (176,009)	$ (9,471,251)	$ (3,052,997)	$ (4,491,271)	$ (52,152,000)
Net cash used in operating activities							(484,024)		(484,024)
Proceeds from sale of Units, net of underwriting discounts paid							484,024		484,024
Net cash provided by financing activities							484,024		484,024
Initial classification of ordinary shares subject to redemption							(12,908,991)		(12,909,000)
Adjustment [Member] | Class A Common Stock [Member]
Class A common stock subject to possible redemption												$ (11,369,991)
Class A common stock	$ 253		$ 338	$ 301	$ 215	$ 253	$ 253	$ 301	$ 284	$ 338	$ 808

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Cash equivalents
Interest earned and withdrawn	303,228	500,620
Unrecognized tax benefits
Amount accrued for interest and penalties
Purchase an aggregate of common stock	17,600,000	17,600,000
FDIC insurance limit	$ 250,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details Narrative) (10-K) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Cash equivalents
Interest earned	303,228	500,620
Unrecognized tax benefits
Amount accrued for interest and penalties
Purchase an aggregate of common stock	17,600,000	17,600,000
Federal depository insurance coverage expense		$ 250,000

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Common Share (Details) - USD ($)	3 Months Ended					4 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2019	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2020
Accounting Policies [Abstract]
Net income	$ 597,052	$ (3,751,049)	$ (8,675,977)	$ 7,772,252	$ (572,263)	$ (573,356)	$ (903,725)	$ (2,881,345)	$ (4,654,774)	$ (51,960,823)
Less: Income attributable to common stock subject to possible redemption	27,616			890,626				$ (848,726)		$ (723,829)
Adjusted net income	$ 569,436			$ 6,881,626
Weighted average common shares subject to possible redemption outstanding, basic and diluted	14,922,915			20,157,878				10,207,641		20,151,440
Basic and diluted income per common share subject to possible redemption	$ 0			$ 0.04				$ 0.08		$ 0.04
Weighted average non-redeemable common shares outstanding, basic and diluted	13,827,085	8,758,829	7,900,920	8,592,122	5,535,597	4,514,200	8,246,521	6,111,484	8,418,537	8,598,542
Basic and diluted net loss per non-redeemable common share	$ 0.04	$ (0.43)	$ (1.10)	$ 0.8	$ (0.13)	$ 0.16	$ (0.22)	$ (0.61)	$ (0.66)	$ (6.13)

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Loss Per Common Share (Details) (10-K) - USD ($)	3 Months Ended					4 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2019	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2020
Accounting Policies [Abstract]
Net loss	$ 597,052	$ (3,751,049)	$ (8,675,977)	$ 7,772,252	$ (572,263)	$ (573,356)	$ (903,725)	$ (2,881,345)	$ (4,654,774)	$ (51,960,823)
Less: Income attributable to common stock subject to possible redemption	$ 27,616			$ 890,626				(848,726)		(723,829)
Adjusted net loss								$ (3,730,070)		$ (52,684,652)
Weighted average common shares subject to possible redemption outstanding, basic and diluted	14,922,915			20,157,878				10,207,641		20,151,440
Basic and diluted income per common share subject to possible redemption	$ 0			$ 0.04				$ 0.08		$ 0.04
Weighted average shares outstanding, basic and diluted	13,827,085	8,758,829	7,900,920	8,592,122	5,535,597	4,514,200	8,246,521	6,111,484	8,418,537	8,598,542
Basic and diluted net loss per common share	$ 0.04	$ (0.43)	$ (1.10)	$ 0.8	$ (0.13)	$ 0.16	$ (0.22)	$ (0.61)	$ (0.66)	$ (6.13)

Initial Public Offering (Detail

Initial Public Offering (Details Narrative) - $ / shares	Sep. 19, 2019	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Exercise price				$ 11.50
Over-Allotment Option [Member]
Sale of units	3,000,000
Purchase price per unit	$ 10
Warrant [Member] | Over-Allotment Option [Member]
Exercise price	$ 1
Class A Common Stock [Member] | Over-Allotment Option [Member]
Sale of units	3,000,000
Purchase price per unit	$ 10
Class A Common Stock [Member] | Public Warrant [Member]
Sale of units		20,000,000	20,000,000
Purchase price per unit		$ 10	$ 10
Exercise price	11.50
Class A Common Stock [Member] | Public Warrant [Member] | Over-Allotment Option [Member]
Exercise price	1
Class A Common Stock [Member] | Warrant [Member]
Exercise price	$ 11.50

Initial Public Offering (Deta_2

Initial Public Offering (Details Narrative) (10-K) - $ / shares	Sep. 19, 2019	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Exercise price				$ 11.50
Over-Allotment Option [Member]
Sale of units	3,000,000
Purchase price per unit	$ 10
Class A Common Stock [Member] | Over-Allotment Option [Member]
Sale of units	3,000,000
Purchase price per unit	$ 10
Class A Common Stock [Member] | Public Warrant [Member]
Sale of units		20,000,000	20,000,000
Purchase price per unit		$ 10	$ 10
Exercise price	11.50
Class A Common Stock [Member] | Public Warrant [Member] | Over-Allotment Option [Member]
Exercise price	$ 1

Private Placement (Details Narr

Private Placement (Details Narrative) - USD ($)	Mar. 31, 2021	Dec. 31, 2019	Sep. 19, 2019
Exercise price		$ 11.50
Warrant [Member] | Over-Allotment Option [Member]
Issue of warrants			600,000
Exercise price			$ 1
Class A Common Stock [Member] | Warrant [Member]
Exercise price			$ 11.50
Class A Common Stock [Member] | Warrant [Member] | Private Placement [Member]
Issue of warrants	5,500,000
Exercise price	$ 1
Purchase price of warrants	$ 5,500,000

Private Placement (Details Na_2

Private Placement (Details Narrative) (10-K) - USD ($)	Dec. 31, 2020	Dec. 31, 2019	Sep. 19, 2019
Exercise price		$ 11.50
Class A Common Stock [Member] | Public Warrant [Member]
Exercise price			$ 11.50
Class A Common Stock [Member] | Public Warrant [Member] | Private Placement [Member]
Issue of warrants	5,500,000
Exercise price	$ 1
Purchase price of warrants	$ 5,500,000
Class A Common Stock [Member] | Public Warrant [Member] | Over-Allotment Option [Member]
Issue of warrants			600,000
Exercise price			$ 1

Fair Value Measurement (Details

Fair Value Measurement (Details Narrative)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Warrant expected term	1 year	1 year	6 years

Fair Value Measurements (Detail

Fair Value Measurements (Details Narrative) (10-K) - USD ($)	4 Months Ended
	Dec. 31, 2019	Mar. 31, 2021	Dec. 31, 2020
Fair Value Disclosures [Abstract]
Warrant term	6 years	1 year	1 year
Measurement of warrants transfer out	$ 13,085,000

Fair Value Measurement - Schedu

Fair Value Measurement - Schedule of Assets Measured at Fair Value on a Recurring Basis (Details Narrative) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Level 1 [Member]
Marketable securities held in Trust Account	$ 231,913,996	$ 232,196,027	$ 231,214,831
Level 1 [Member] | Public Warrant [Member]
Liabilities fair value disclosure	40,710,000	43,470,000	10,350,000
Level 2 [Member] | Private Placement Warrant [Member]
Liabilities fair value disclosure	$ 25,376,000	$ 24,644,000	$ 5,612,000

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Assets Measured at Fair Value On a Recurring Basis (Details) (10-K) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Level 1 [Member]
Marketable securities held in Trust Account	$ 231,913,996	$ 232,196,027	$ 231,214,831
Level 1 [Member] | Public Warrant [Member]
Liabilities fair value disclosure	40,710,000	43,470,000	10,350,000
Level 2 [Member] | Private Placement Warrant [Member]
Liabilities fair value disclosure	$ 25,376,000	$ 24,644,000	$ 5,612,000

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Initial Measurement (Details) (10-K)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019$ / shares
Exercise price			$ 11.50
Fair value of units			$ 10.04
Contractual term (years)	1 year	1 year	6 years
Volatility [Member]
Fair value measurement input			11
Risk-Free Rate [Member]
Fair value measurement input			1.62

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Changes in the Fair Value of Warrant Liabilities (Details) (10-K) - USD ($)	1 Months Ended	3 Months Ended					4 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2019	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2020
Beginning balance		$ 68,114,000	$ 17,661,000	$ 9,037,000	$ 15,962,000			$ 15,962,000		$ 15,962,000	$ 15,962,000
Initial measurement									12,909,000
Changes in fair value	$ 4,514,000	(2,028,000)	3,696,000	8,624,000	(6,925,000)	$ 176,000	176,000	1,699,000	3,053,000	5,395,000	52,152,000
Ending balance	$ 13,085,000	66,086,000	$ 21,357,000	$ 17,661,000	9,037,000	$ 13,085,000	13,085,000	17,661,000	15,962,000	21,357,000	68,114,000
Public Warrant [Member]
Beginning balance		43,470,000			10,350,000			10,350,000		10,350,000	10,350,000
Initial measurement									8,395,000
Changes in fair value									1,955,000		33,120,000
Ending balance									10,350,000		43,470,000
Private Placement Warrant [Member]
Beginning balance		$ 24,644,000			$ 5,612,000			$ 5,612,000		$ 5,612,000	5,612,000
Initial measurement									4,514,000
Changes in fair value									1,098,000		19,032,000
Ending balance									$ 5,612,000		$ 24,644,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	Sep. 13, 2019	Sep. 30, 2019	Aug. 31, 2019	Jun. 30, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Feb. 18, 2021	Jan. 28, 2021	Aug. 23, 2019	Aug. 22, 2019	Jun. 20, 2019
Aggregate purchased shares					17,600,000			17,600,000
Stock issued during period, shares							23,000,000	23,000,000
Shareholders ownership, percentage					20.00%			20.00%
Stock splits, description					(A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company's Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company's stockholders having the right to exchange their shares of common stock for cash, securities or other property.			(A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company's Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company's stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Accounts payable and accrued expenses					$ 10,000		$ 35,000	$ 30,000
Related party loans, description					Up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant			Up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant
Sponsor [Member]
Loan amount					$ 600,000				$ 500,000	$ 200,000
Sponsor amount	$ 10,000				$ 30,000	$ 30,000
Promissory Note [Member]
Loan amount													$ 300,000
Repaid aggregate amount		$ 155,093
Founder Shares [Member]
Number of shares transferred			10,000
Aggregate of shares forfeiture over-allotment option					750,000			750,000
Class B Common Stock [Member]
Number of shares outstanding											5,750,000	3,593,750
Class B Common Stock [Member] | Founder Shares [Member]
Aggregate purchased shares				3,593,750
Aggregate purchase price				$ 25,000
Stock issued during period, shares					5,750,000			5,750,000
Class B Common Stock [Member] | Founder Shares [Member] | Maximum [Member]
Aggregate of shares forfeiture over-allotment option					750,000			750,000

Related Party Transactions (D_2

Related Party Transactions (Details Narrative) (10-K) - USD ($)	Sep. 13, 2019	Sep. 30, 2019	Aug. 31, 2019	Jun. 30, 2019	Jun. 20, 2019	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Aug. 23, 2019	Aug. 22, 2019
Aggregate purchased shares						17,600,000			17,600,000
Stock issued during period, shares								23,000,000	23,000,000
Shareholders ownership, percentage						20.00%			20.00%
Stock splits, description						(A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company's Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company's stockholders having the right to exchange their shares of common stock for cash, securities or other property.			(A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Company's Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company's stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Accounts payable and accrued expenses						$ 10,000		$ 35,000	$ 30,000
Related party loans, description						Up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant			Up to $1,500,000 of notes may be converted upon consummation of a Business Combination into warrants at a price of $1.00 per warrant
Sponsor [Member]
Sponsor amount	$ 10,000					$ 30,000	$ 30,000
Services fees								$ 35,000	$ 120,000
Promissory Note [Member]
Aggregate unsecured promissory note amount					$ 300,000
Repaid aggregate amount		$ 155,093
Founder Shares [Member]
Sponsor founder shares			10,000
Aggregate of shares forfeiture over-allotment option						750,000			750,000
Class B Common Stock [Member]
Number of shares outstanding										5,750,000	3,593,750
Class B Common Stock [Member] | Founder Shares [Member]
Aggregate purchased shares				3,593,750
Aggregate purchase price				$ 25,000
Stock issued during period, shares						5,750,000			5,750,000
Class B Common Stock [Member] | Founder Shares [Member] | Maximum [Member]
Aggregate of shares forfeiture over-allotment option						750,000			750,000

Commitments (Details Narrative)

Commitments (Details Narrative) - USD ($)	Dec. 15, 2020	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Underwriters agreement, description		The underwriters of the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. Up to 40% of such amount (or $3,220,000) may be paid at the sole discretion of the Company's management team to the underwriters in the allocations determined by the management team and/or to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in completing a Business Combination.	The underwriters of the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. Up to 40% of such amount (or $3,220,000) may be paid at the sole discretion of the Company's management team to the underwriters in the allocations determined by the management team and/or to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in consummating a Business Combination.
Percentage of business combination		40.00%	40.00%
Equity purchase agreement, description	(a) change the name of the Company to AST SpaceMobile, Inc., (b) convert all then-outstanding Founder Shares, excluding any Forfeited Founder Shares into shares of Class A common stock, par value $0.0001 per share, of SpaceMobile ("Class A Common Stock") and (c) authorize the issuance of Class B common stock, par value $0.0001 per share, of SpaceMobile ("Class B Common Stock") and Class C common stock, par value $0.0001 per share, of SpaceMobile ("Class C Common Stock") and (ii) replace the Amended and Restated By-Laws of the Company (the "Existing Bylaws"), by adopting the Bylaws of AST SpaceMobile, Inc. (the "SpaceMobile Bylaws").
Deposit from investors		$ 50,000,000
Class A Common Stock [Member] | Subscription Agreements [Member] | Investor [Member]
Investments	$ 230,000,000
Class A Common Stock [Member] | Subscription Agreements [Member] | PIPE Investors [Member]
Equity purchase agreement, description	The Company entered into various subscription agreements (the "Subscription Agreements") with certain third-party investors wherein the investors have committed to make private investments in public equity ("PIPE") in the form of Class A Common Stock in an aggregate amount of $230 million (the "PIPE Investment"). In exchange for the PIPE Investment, these "PIPE Investors" will receive an aggregate of 23 million shares of Class A Common Stock.

Commitments (Details Narrativ_2

Commitments (Details Narrative) (10-K)	Dec. 15, 2020	Mar. 31, 2021	Dec. 31, 2020
Underwriters agreement, description		The underwriters of the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. Up to 40% of such amount (or $3,220,000) may be paid at the sole discretion of the Company's management team to the underwriters in the allocations determined by the management team and/or to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in completing a Business Combination.	The underwriters of the Initial Public Offering are entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate. Up to 40% of such amount (or $3,220,000) may be paid at the sole discretion of the Company's management team to the underwriters in the allocations determined by the management team and/or to third parties not participating in the Initial Public Offering (but who are members of FINRA) that assist the Company in consummating a Business Combination.
Percentage of business combination		40.00%	40.00%
Equity purchase agreement, description	(a) change the name of the Company to AST SpaceMobile, Inc., (b) convert all then-outstanding Founder Shares, excluding any Forfeited Founder Shares into shares of Class A common stock, par value $0.0001 per share, of SpaceMobile ("Class A Common Stock") and (c) authorize the issuance of Class B common stock, par value $0.0001 per share, of SpaceMobile ("Class B Common Stock") and Class C common stock, par value $0.0001 per share, of SpaceMobile ("Class C Common Stock") and (ii) replace the Amended and Restated By-Laws of the Company (the "Existing Bylaws"), by adopting the Bylaws of AST SpaceMobile, Inc. (the "SpaceMobile Bylaws").
Subscription Agreements [Member]
Equity purchase agreement, description	The Company entered into various subscription agreements (the "Subscription Agreements") with certain third-party investors (the "PIPE Investors") pursuant to which the PIPE Investors have committed to make private investments in public equity in the form of Class A Common Stock in an aggregate amount of $230 million (the "PIPE Investment"). In exchange for the PIPE Investment, the PIPE Investors will receive an aggregate of 23 million shares of Class A Common Stock.

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued
Preferred stock, shares outstanding
Shares subject to redemption	$ 14,982,488	$ 14,922,915	$ 20,157,878
Shareholders ownership, percentage	20.00%	20.00%
Class A Common Stock [Member]
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued	8,017,512	8,077,085	2,842,122
Common stock, shares outstanding	8,017,512	8,077,085	2,842,122
Class B Common Stock [Member]
Common stock, shares authorized	10,000,000	10,000,000	10,000,000
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued	5,750,000	5,750,000	5,750,000
Common stock, shares outstanding	5,750,000	5,750,000	5,750,000

Stockholders' Equity (Details_2

Stockholders' Equity (Details Narrative) (10-K) - $ / shares	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Preferred stock, shares authorized	1,000,000	1,000,000	1,000,000
Preferred stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares issued
Preferred stock, shares outstanding
Shareholders ownership, percentage	20.00%	20.00%
Class A Common Stock [Member]
Common stock, shares authorized	100,000,000	100,000,000	100,000,000
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued	8,017,512	8,077,085	2,842,122
Common stock, shares outstanding	8,017,512	8,077,085	2,842,122
Class B Common Stock [Member]
Common stock, shares authorized	10,000,000	10,000,000	10,000,000
Common stock, par value	$ 0.0001	$ 0.0001	$ 0.0001
Common stock, shares issued	5,750,000	5,750,000	5,750,000
Common stock, shares outstanding	5,750,000	5,750,000	5,750,000

Warrant Liabilities (Details Na

Warrant Liabilities (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended					4 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2019	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2020	Sep. 13, 2019	May 27, 2019
Share based compensation description		if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company's board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceed, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company's common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.									if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company's board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceed, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company's common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
Warrant liabilities	$ 13,085,000	$ 66,086,000	$ 21,357,000	$ 17,661,000	$ 9,037,000	$ 13,085,000	$ 13,085,000	$ 17,661,000	$ 15,962,000	$ 21,357,000	$ 68,114,000	$ 11,370,000
Change in fair value of warrant liabilities	(4,514,000)	$ 2,028,000	$ (3,696,000)	$ (8,624,000)	$ 6,925,000	$ (176,000)	$ (176,000)	$ (1,699,000)	$ (3,053,000)	$ (5,395,000)	$ (52,152,000)
Public Warrants [Member]
Warrant description		Once the warrants become exercisable, the Company may redeem the Public Warrants: In whole and not in part; At a price of $0.01 per warrant; Upon a minimum of 30 days' prior written notice of redemption; and If, and only if, the reported last sale price of the Company's Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.									Once the warrants become exercisable, the Company may redeem the Public Warrants: in whole and not in part; at a price of $0.01 per warrant; upon a minimum of 30 days' prior written notice of redemption; and if, and only if, the reported last sale price of the Company's Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
Change in fair value of warrant liabilities	$ (8,395,000)

Warrant Liabilities (Details _2

Warrant Liabilities (Details Narrative) (10-K) - USD ($)	1 Months Ended	3 Months Ended					4 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2019	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Dec. 31, 2020	Sep. 13, 2019	May 27, 2019
Share based compensation description		if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company's board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceed, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company's common stock during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.									if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company's board of directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the "Newly Issued Price"), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceed, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company's common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the "Market Value") is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
Change in fair value of warrant liabilities	$ 4,514,000	$ (2,028,000)	$ 3,696,000	$ 8,624,000	$ (6,925,000)	$ 176,000	$ 176,000	$ 1,699,000	$ 3,053,000	$ 5,395,000	$ 52,152,000
Proceeds from issuance of offering	1,586,000										13,260,927
Warrant liabilities	13,085,000	$ 66,086,000	$ 21,357,000	$ 17,661,000	$ 9,037,000	$ 13,085,000	$ 13,085,000	$ 17,661,000	$ 15,962,000	$ 21,357,000	$ 68,114,000	$ 11,370,000
Public Warrants [Member]
Warrant description		Once the warrants become exercisable, the Company may redeem the Public Warrants: In whole and not in part; At a price of $0.01 per warrant; Upon a minimum of 30 days' prior written notice of redemption; and If, and only if, the reported last sale price of the Company's Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.									Once the warrants become exercisable, the Company may redeem the Public Warrants: in whole and not in part; at a price of $0.01 per warrant; upon a minimum of 30 days' prior written notice of redemption; and if, and only if, the reported last sale price of the Company's Class A common stock equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.
Change in fair value of warrant liabilities	$ 8,395,000
Proceeds from issuance of offering											$ 484,024

Income Tax - Schedule of Net De

Income Tax - Schedule of Net Deferred Tax Liability (Details) (10-K) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Unrealized gain on marketable securities	$ (9,680)	$ (3,611)
Total deferred tax liability	(9,680)	(3,611)
Valuation Allowance
Deferred tax liability, net of allowance	$ (9,680)	$ (3,611)

Income Tax - Schedule of Provis

Income Tax - Schedule of Provision for Income Taxes (Details) (10-K) - USD ($)	7 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Federal Current	$ 170,684	$ 159,877
Federal Deferred	3,611	6,069
State and Local Current
State and Local Deferred
Change in valuation allowance
Income tax provision	$ 174,295	$ 165,946

Income Tax - Schedule of Federa

Income Tax - Schedule of Federal Income Tax Rate (Details) (10-K)	7 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Statutory federal income tax rate	21.00%	21.00%
Change in fair value of warrant liabilities	(27.40%)	(21.10%)
Business Combination expenses	0.00%	(0.20%)
Income tax provision	(6.40%)	(0.30%)

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 06, 2021	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2020
Stock issued during period, shares				23,000,000	23,000,000
Stock issued during period, value				$ 208,828,097
Redemptions amount		$ (597,052)	$ (7,772,252)	(202,557,751)
Repayment of related party loan				$ 155,093
Class B Common Stock [Member]
Common stock, par value		$ 0.0001		$ 0.0001	$ 0.0001
Class A Common Stock [Member]
Common stock, par value		$ 0.0001		$ 0.0001	$ 0.0001
Subsequent Event [Member] | Warrant [Member]
Warrants to purchase	17,600,000
Subsequent Event [Member] | Equity Purchase Agreement [Member]
Stock issued during period, shares	51,729,704
Stock issued during period, value	$ 227,000,000
Subsequent Event [Member] | Equity Purchase Agreement [Member] | Stockholders [Member]
Payment of deferred underwriting commissions	4,800,000
Redemptions amount	200,000
Repayment of related party loan	$ 600,000
Subsequent Event [Member] | Class B Common Stock [Member]
Stock issued during period, shares	51,636,922
Subsequent Event [Member] | Class B Common Stock [Member] | Sponsor [Member] | Equity Purchase Agreement [Member]
Common stock, par value	$ 0.0001
Subsequent Event [Member] | Class A Common Stock [Member]
Stock issued during period, shares	23,000,000
Subsequent Event [Member] | Class A Common Stock [Member] | New Providence Acquisition Management LLC [Member]
Redemptions amount	$ 85,348
Stock issued during period, acquisitions shares	8,460
Share redemption price per share	$ 10.09
Subsequent Event [Member] | Class A Common Stock [Member] | Sponsor [Member] | Equity Purchase Agreement [Member]
Common stock, par value	$ 0.0001
Subsequent Event [Member] | Class C Common Stock [Member]
Stock issued during period, shares	78,163,078
Subsequent Event [Member] | Class C Common Stock [Member] | Sponsor [Member] | Equity Purchase Agreement [Member]
Common stock, par value	$ 0.0001

Subsequent Events (Details Na_2

Subsequent Events (Details Narrative) (10-K) - USD ($)	Feb. 18, 2021	May 28, 2021	Mar. 31, 2021	Feb. 26, 2021	Jan. 28, 2021
Subsequent Event [Member]
Borrowings				$ 300,000
Sponsor [Member]
Aggregate of amount	$ 500,000		$ 600,000		$ 200,000
Sponsor [Member] | Subsequent Event [Member]
Agreed to loan	500,000				200,000
Aggregate of amount	$ 700,000				$ 700,000
Description of subsequent events	The Notes are non-interest bearing and payable on the earlier of June 30, 2021 or the completion of the Business Combination.	The Notes are non-interest bearing and payable on the earlier of June 30, 2021 or the completion of the Business Combination.